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Abstract  
Sparsely ionizing radiation (IR) deposits energy in spurs and blobs where multiple 
ionizations occur in a small volume. If generated close to DNA, such events induce 
multiple lesions within few base pairs (complex lesions) and damage both base and 
sugar moieties. These energy deposition events are closely confined to the paths of the 
constituent ionizing particles. The distances between subsequent ionization events vary 
randomly along the particle path, and decrease as the particle slows down and comes to 
a halt. Thus, at all ends of electron tracks, where X-ray energy is mainly deposited, 
excessive local accumulation of ionizations will generate complex DNA damage that is 
thought to be primarily responsible for the observed adverse cellular effects.  
The DNA double strand break (DSB) is the simplest form of a complex lesion, generated 
when two ionizations, or radiation-induced radicals, in close proximity disrupt the sugar 
phosphate backbone of the two DNA strands. Further complexity, and thus also 
increased risk for biological consequences, is generated when additional lesions occur 
near the DSB. Such complex damage is presently intensively studied and is implicated 
in the biological effects of high LET radiation. Another dimension of complexity and a 
particularly high risk for biological consequences is generated when two (or more) DSBs 
are induced in close proximity, as they may completely destabilize chromatin and may 
cause DNA losses that cannot be dealt by available DNA repair pathways. Although this 
form of complex DNA lesion has been considered in the past, mechanistic studies able 
to analyze its biological consequences are lacking.   
In vitro manipulation of the plasmid DNA allows the generation of DSBs with different but 
well-defined ends, usually generated by treatment with appropriate combinations of 
restriction endonucleases. While these assays recapitulate important aspects of D-
NHEJ, several reports show that they fail to reproduce the marked reduction in DNA end 
joining efficiency of genomic DSBs observed in a variety of D-NHEJ mutants, suggesting 
that they mainly reflect the function of B-NHEJ. In preparation for the above mentioned 
studies on complex lesions we also examined the effect of the transfection method on 
repair pathways selection. We discovered that while electroporation generates plasmid 
end joining results in the different mutants closely reflecting rejoining of genomic DSBs, 
plasmid lipofection-generated results showing a nearly wild type plasmid end joining 
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efficiency in D-NHEJ mutants. We show that the subcellular localization of the 
transfected plasmid underlies these differences.  
With this information at hand, we began studies to test the hypothesis that clustering of 
DSBs at distances affecting nucleosomal or local chromatin stability is highly lethal for 
the cell. Rather than mathematically modeling energy deposition and the general 
features of clustered damage induction and fitting the model to the biological effects 
measured, here we model the biological lesion in a highly specific way by narrowing 
down on the candidate lesion and testing for key biological consequences. This 
approach has the advantage that it allows the characterization of the general properties 
of radiation lesions causing mutations and cell lethality.  
We describe model systems in which DSB clusters are induced in the genome of human 
tumor A549 cells through enzymatic restriction of I-SceI sites integrated at different 
combinations and at multiple sites using transposon technology. To address complexity, 
we generated transposon-based constructs harboring a single and two I-SceI sites in 
compatible and incompatible orientations separated by 200bp. The vector used also 
contains the neoR gene as a selectable marker. The integration of the plasmid at 
multiple sites is facilitated by co-expression of a hyperactive transposase artificially 
reactivated from the “Sleeping Beauty” transposon. The number of integration sites is 
measured in randomly selected G418 resistant clones using Southern blotting and sets 
are generated with clones harboring 3-12 integration sites for each DSB arrangement.  
Using these sets of clones, cell survival by colony formation, as well as chromosomal 
aberration formation along with other techniques like mitotic index/G2-checkpoint 
activation, and induction of EGFP-53BP1 foci are studied. The results obtained as part 
of this thesis show a correlation between lesion complexity and cell killing. Evidence for 
checkpoint activation and chromosome aberration formation is also obtained, but 
analysis of these endpoints is hampered by the apoptotic response of the generated 
system. More work will be necessary to define and improve the potential of this model 
system for radiation damage. 
 
Key words: Ionizing radiation, Transposon, Complex lesion, LET, Nucleofection, 
Lipofection, Chromatin, D-NHEJ and B-NHEJ. 
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1 Introduction 
1.1.   DNA double strand break repair pathways 
The DNA double strand break is the single most lethal lesion known for a proliferating 
cell and also a major cause of mutagenesis leading to a carcinogenic outcome [1]. DSBs 
are known to be the most biological dangerous lesions induced by ionizing radiation like 
x- and γ rays (IR) [2]. DNA DSBs can also be induced by radiomimetic chemical agents 
like bleomycin [3], neocarzinostatin [4], and calicheamycin [5], among others. DSBs are 
also created as secondary lesions by chemicals like methyl methane sulphonate 
(MMS)[6], which modifies DNA structure by methylating its bases and thus forms DSB 
upon replication fork collapse. DSBs are also induced indirectly by topoisomerase I 
inhibitors like camptothecin [7]. Topoisomerase II inhibitors like etoposide induce DSBs 
both directly and through the formation of stabilized cleavage complex (SCC) [8, 9]. 
Double strand breaks are an unavoidable evil for the cells, as they are inadvertently 
generated during replication, and are required during meiosis [10] and V(D)J 
recombination. Yet, they are also a major cause of viability loss. V(D)J recombination 
[11, 12] is utilized in developing B and T lymphocytes in the vertebrate immune system 
to generate antigen diversity by randomly recombining of a large pool of germline V, D, 
and J gene segments. Accidental introduction of a DSB takes place in a cell when a 
SSB encounters an active replication fork during the S-phase of the cell cycle or as a 
consequence of abortive function of Topoisomerases I and II [13]. 
The double strand breaks created by ionizing radiation pose a paramount risk and 
challenge for the cell. Each Gy of radiation is conservatively estimated to induce at least 
30-60 DSBs, approx. 1500 single strand breaks and 4500 base or other damages[14].  
The single strand break repair pathway is well characterized in mammalian cells and 
also in lower eukaryotes and prokaryotes. Mammalian cells utilize two major pathways 
for repairing DSBs, namely the DNA-PK-dependent non homologous end joining and 
Homologous recombination [15, 16] see Figure 1, although the presence of other 
pathways like single strand annealing [17] and Backup-NHEJ [18-20] are also known. 
HRR utilizes the products of genes of the Rad52 epistasis group and restores the DNA 
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sequence around the break with the help of a homologous sequence predominantly 
found in the sister chromatid but occasionally also in the homologous chromosome. It is 
the predominant DSB repair mechanism in yeast. In higher eukaryotes, HRR appears 
restricted to the G2 and S-phase of the cell cycle where it utilizes the sister chromatid, 
but its relative contribution to the repair of accidental DSBs remains uncharacterized.  
NHEJ appears to be the dominant DSB repair pathway in higher eukaryotes. During 
NHEJ, the two DNA ends are enzymatically captured and rejoined after end processing 
that enables ligation. End processing causes nucleotide gains or losses that can at 
times be extensive. As a result, NHEJ restores DNA integrity without achieving the 
restoration of DNA sequence. It should therefore be regarded as a repair pathway with a 
restricted task. The classical form of NHEJ comprises DNA-PKCS, Ku70, Ku80, XRCC4, 
DNA Ligase4, and XLF/Cernunnos; it will be referred to here as D-NHEJ, to indicate its 
dependence on DNA-PK. Recent work indicates the function of an alternative pathway 
of NHEJ that operates as a backup (B-NHEJ) whenever D-NHEJ is compromised – 
chemically or genetically. B-NHEJ utilizes PARP-1, XRCC1, and DNA Ligase III and 
may benefit from additional DNA repair and signaling factors such as NBS1 and CtIP 
[21-23]. 
 
 
 
 
 
 
 
 
 
 
        
          Fig. 1: Schematic representations of NHEJ and HRR mechanisms [24]. 
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1.1.1 DNA damage response (DDR)  
The utilization of ionizing radiation in medical diagnostics and therapy makes it 
imperative to study and characterize the pathways of DNA DSB repair to have an in 
depth understanding of how a cell recognizes, responds and ultimately eliminates these 
lesions, also called as DNA damage response or DDR, Figure 2.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Model for DDR. The presence of a lesion in the DNA, which can lead to 
replication stalling, is recognized by various sensor proteins. These sensors initiate 
signaling pathways that have an impact on a wide variety of cellular processes [13]. 
 
To prevent these cytotoxic lesions from progressing to chromosomal breaks and 
genomic instability, cells have devised efficient and cooperative DNA break repair 
pathways, which are known to have (and also being actively investigated) for 
overlapping functions.  These repair proteins can be classified into sensors, like the 
Mre11, Rad50, NBS1 complex [25-31] and Ku70/80 dimer [32, 33], signal amplifiers like 
γ-H2AX [34-36], 53BP1 [37-39] and ATM/ATR [27, 40], and actual effectors of ligation of 
the ends like the Lig4/XRCC4/XLF [41-46] and Ligase III/XRCC1 [19, 20, 47] 
complexes.   
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1.1.2 Induction of DNA damage by ionizing radiation 
The character of a DSB created by IR is one of the hotly pursued areas of radiation 
biology and DNA repair. Initial knowledge on DNA behavior upon irradiation came from 
studies of radiolytic reactions of DNA either in dry state (by electron-spin-resonance 
spectroscopy/ESR), or irradiated aqueous solutions of biomolecules in vitro to 
understand their effects in vivo. Induction of DSBs by IR takes place primarily by two 
mechanisms. First, by direct ionization in both DNA strands can induce DSBs. Second, 
hydroxyl radicals formed from the interaction of IR with water molecules can induce 
DSBs indirectly if the attack both DNA strands, Figure 3. Sparsely ionizing radiations like 
the x- and γ-rays cause more indirect damage to the DNA, in contrast to high LET 
radiations, which primarily damage DNA directly [48-51], Figure 4A and B.  
 
 
 
 
 
 
 
Fig. 3: Schematic representation of direct and indirect action of IR. Illustration 
courtesy: Canadian Nuclear Association website. 
 
Other than DNA double and single strand breaks, ionizing radiation also induces a vast 
array of lesions, like the alkali labile lesions [52] (ALL; this damage on DNA bases and 
sugars rises linearly with dose and is sensitive to alkylating agents leading to a DSB), 
heat labile sites (sensitive to heat and may get converted to a DSB) [53, 54], base 
lesions (oxybases; oxypurines and oxypyrimidines, like FaPy Adenine, FaPy Guanine, 
C8-oxoGuanine, C8-oxoAdenine are examples of oxypurines; Thymine residues 
damaged by ring saturation, fragmentation, or ring contraction including thymine glycol 
and uracil residues are examples of oxypyrimidines) [55, 56] and regular and oxidized 
AP sites (apurinic and apyrimidinic sites with abasic sites modified with alkoxyamines 
and DNA containing urea residues) [57, 58], single interruptions on the sugar-phosphate 
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backbone, fragile sites on DNA, S1-sites and DNA-protein cross-links (formed due to the 
close association and interaction of DNA and proteins (histones) in chromatin, 
preferentially under hypoxic conditions). Comparison of radiosensitivities of bases of 
irradiated DNA has shown increasing radiosensitivities from Guanine (G) to Adenine (A) 
to Cytosine (C) and then to Thymine (T), which is in agreement with the formation and 
prevalence of best known radiation products thymine glycol and thymine 
hydroxyhydroperoxide on the C5-C6-double bond upon irradiation, which are the 
oxidation products of thymine [59]. 
Chemical alteration due to direct ionization of the molecules and free radical attack 
leads to degradation of biomolecules and induction of cross-linking, inter-cross-linking of 
the DNAs, proteins, lipids etc. All these forms of damage alter the structural 
conformation of the biomolecules, resulting in genetic and cell structure alterations and 
lead to metabolic changes in the cell. These alterations can ultimately cause mutation, 
transformation and cell death. The mechanisms leading to the observable cellular 
effects are complex, but there is evidence that they are mediated by the formation of 
chromosomal aberrations. 
 
1.1.3 Introduction to LET in relation to DNA damage 
Linear Energy Transfer (LET) is defined as the energy, which an ionizing particle 
deposits per unit distance as it traverses matter. It is the quotient dE/dl, where dE is the 
average energy locally imparted to the medium by a charged particle of specified energy 
in traversing a distance of dl. 
L.E.T = dE/dl 
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 LET is used to quantify the effects of ionizing radiation on biological specimens or 
electronic devices. Medical X-rays are low LET radiation, while, alpha particles and other 
heavier nuclei have a much higher LET. LET varies enormously depending on the speed 
and charge of the particle involved. The biological effects of high LET radiations are in 
general much higher than those of low LET radiations at the same dose [60, 61]. This is 
because high LET radiation can deposit most of its energy within a small volume and to 
produce in this way highly accumulated damage, see Figures 4A and B [62]. Each 
particle has a unique track structure and the distances between ionizations vary randomly 
on a track but decreases on the average as particles lose energy along their paths [63] 
[50, 64-67]. Electrons display large increases in the density of ionizations at the ends of 
their tracks. It has also been proposed that a break created by high LET radiation 
remains unrepaired over a substantial period of time [68]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4A: Illustration of historical development of descriptions of radiation tracks 
[64].
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Fig. 4B: 2D projection of track-structure segments in liquid water for different ions 
with the same velocity (115 MeV nucleon–1) as calculated with the PARTRAC code 
(from top to bottom and from left to right: H, He, C and Fe; note the different scale for the 
proton track). (Ballarini F. et al. New J. Phys.10 (2008)) 
 
 
The increased effectiveness of high LET radiations can be inferred from the fact that 
their survival curves are linear on a semi-logarithmic plot, whereas they curvilinear 
("shouldered") for low LET radiation, see Figure 5.  
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Fig. 5: Survival curve plot obtained with high (A) and low LET radiation (B).  
 Illustration Courtesy: http://ocw.mit.edu/terms 
 
1.2.  Introduction to complex lesions 
Since the effects of radiation are stochastic, the breaks and other forms of damage 
created by IR are not in distinct and definite regions of the genome, but random (in 
broader terms) and extremely diverse. This gives rise to the possibility of induction of a 
complex lesion. A cluster of closely-spaced DNA lesions of same or different nature 
including single strand breaks, oxidized base lesions (oxybases; oxypurines and 
oxypyrimidines) [58] and regular and oxidized AP sites, which are produced in close 
proximity to each other, generally within 1 - 2 helical turns of DNA molecule and on 
opposite strands (bistranded lesions) has traditionally been accepted as the description 
of a complex lesion, a hallmark of high LET radiations, like neutrons and α-particles. 
Complex or clustered lesions constitute nearly 50-80% of the damage induced by IR 
[55]. Clustered lesions are resistant to processing by glycosylases and endonucleases 
and remain persistent in the genome for a significant amount of time after irradiation and 
are considered to be highly mutagenic [48].  
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1.2.1 Complex lesions induced by low and high LET radiations 
Clustering of DNA lesions depends on chromatin structure and LET of the radiation, see 
Figure 6. For low LET radiations, the clustering occurs on the small scales of DNA 
molecules and nucleosomes, whereas for high LET radiations, the clustering of lesions 
is also seen on a much larger scale with chromatin state dependency. 
There are various theories put forth for the same over the years by radiation chemists, 
like the theory of Locally Multiply Damaged Sites (LMDS) [69] and Regionally Multiply 
Damaged Sites (RMDS) [70]. LMDS theory explains that energy from ionizing radiation 
tends to localize along the tracks of charged particles and is not absorbed uniformly. 
This energy is deposited in the form of spurs and blobs, which contain a number of ion 
pairs (blobs more than spurs) and have a similar dimension as the DNA double helix. 
With the increase of LET or in high LET radiations like neutrons and α-particles, the 
number of blobs created is greatly enhanced, thus resulting in increased lethality. 
Theory of RMDS highlights the 30-nm chromatin fiber as the target for ionizing particles. 
Experiments showed that DNA fragments in the size range of 0.1-2 kb were formed 
linearly with dose with an efficiency that increased with LET. A comparison of the yield 
of such fragments with the yield of total DNA double-strand breaks suggests that for the 
high- LET ions a substantial proportion (20-90%) of DNA double-strand breaks are 
accompanied within 0.1-2 kb by at least one additional DNA double-strand break[70]. 
The crucial features of association of damage could be at any one or more of the 
following levels of structures: clustering of damage at the level of the DNA helix, or in 
higher-order DNA structures such as nucleosomes (theory of Multiple damaged sites or 
MDS) [14]; spatial association of separate points of damage such as across a chromatin 
fiber, or between adjacent chromatids [71]; in other target molecules or structures; or the 
simultaneity (in <10 -12 s) of the overall burden to the cell nucleus, such as the ~200 
DNA single-strand breaks (SSB) and ~20 DSB from the traversal of a single α-particle. 
Attempts have been made also to evaluate the yields of SSB and DSB for various 
radiation types, either from direct ionizations in the DNA, indirect effects from nearby 
hydroxyl radicals or combinations of both [50, 72], which revealed that a high proportion 
of the DSBs have additional associated damage, such as base damage and additional 
strand breaks within the same very short segment of DNA [73, 74]. This clustered 
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damage at the DNA level appears to be a feature of virtually all ionizing radiations, 
although its frequency and severity depend on the radiation quality.  
 
1.2.2 Cell lethality in relation to complex lesions 
A combination of the complexity or distribution of lesions, repair enzyme levels and 
access to damage are major factors which influence DNA repair. The distribution of 
damage within higher-order chromatin structures and the position of double-strand 
breaks (DSBs) relative to other breaks have been suggested to play critical roles in the 
repair of DNA damage, the formation of chromosomal aberrations and the clonogenic 
survival of cells. One of the suggested models for reproductive cell killing involves a 
"paired" DSB mechanism, where it has been hypothesized that potentially lethal damage 
(PLD) might result from two DSBs produced by a single track that are separated by 
relatively large distances [75]. This model was proposed to be consistent with the 
dependence of cell lethality on linear energy transfer (LET) and inferred that packaging 
of DNA within the nucleus might play a role, not only in the numbers of induced DSBs 
but also in their distribution within the chromatin. Another Poisson-based model of 
induction of DSBs and elution of DNA from residual nuclear structures was proposed, 
which speculated that elution of DNA from nucleoids could occur only if two or more 
DSBs were induced within a single looped domain. Multiple DSBs within these 
structures released the segment of non-matrix-bound DNA delineated by two DSBs, 
thus allowing its elution [75-77] [78]. 
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Fig. 6: Classification scheme (right hand side) used for scoring clustered damage 
in DNA due to multiple strand breaks. Schematic diagrams on the left illustrate typical 
examples of strand breakage (solid symbols), but also include examples of associated 
base damage (open symbols) [64]. 
 
1.3.  Induction of DNA double strand breaks without utilizing IR or 
radiomimetic compounds 
As discussed earlier, due to the stochastic nature of its effects, IR is not an optimum tool 
for the study of the effects elicited to only DNA double strand breaks as it also induces a 
multitude of other types of lesions adding new dimensions of complexity. IR-induced 
DSBs also cannot be placed in a controlled manner and their location, type and number 
varies stochastically from one cell to another. Hence, the effect of repair or misrepair of 
a single type of lesion can never be studied as all methods currently used take into 
account the collective response of all cells, thus masking or losing the fine details for the 
types of radiation induced damages which are most lethal to the cell. 
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One of the approaches to characterize the pathways of DSB repair is to monitor the 
repair of site-specific DSBs generated by rare-cutting endonucleases, such as I-SceI 
[79-81]. Utilizing a single I-SceI site, a study demonstrated that broken ends are 
positionally stable and unable to roam the cell nucleus and require the DNA end binding 
protein Ku80. Repair was independent of DNA repair factors, γ-H2AX, the MRN complex 
and the cohesion complex. In this study, a single DSB could be induced at a defined 
genomic site and the fate of each of the two damaged DNA ends could be tracked in 
real time [82]. Another study [83] utilized the presence of nearly 200-300 endogenous I-
PpoI sites in the human genome for induction of DSBs and used the system to detect 
protein recruitment and loss at and around these breaks by chromatin 
immunoprecipitation (ChIP). DSB formation led to the localized disruption of 
nucleosomes, a process that depended on both functional NBS1 and ATM, which were 
also required for the efficient recruitment of the repair factor XRCC4 to DSBs and for 
efficient DSB repair. A study with two I-SceI sites, in correct or reverse orientation [84], 
separated by the H2-KD and CD8 genes, showed that I-SceI sites in correct orientation 
were rejoined either accurately or caused extended deletions. On the other hand, I-SceI 
sites in reverse orientation generated non-fully complementary ends for CD4 
expression. DSB repair under these conditions either led to extended deletion or used 
the annealing of two of the four protruding nucleotides. Another study utilized a NHEJ 
reporter construct based on two I-SceI sites in reverse orientation for determining the 
importance of Ku and XRCC4 proteins in non-homologous end joining pathway [85]. 
Two I-SceI site constructs were also used to study the contribution of various repair 
factors like Ku, CtIP, Rad51, Rad52 and ERCC1 in alternative non-homologous end 
joining (alt-NHEJ), HDR and SSA. [86]. The same constructs are utilized to decipher the 
roles of ERCC1, Msh2, Nbs1, XRCC4, and BRCA1 in the above mentioned pathways 
[87]. Another study involving two I-SceI sites dealt with the choice of repair pathway for 
a type of DSB and demonstrated that non-RAG mediated DSBs are forced into the 
NHEJ repair pathway by physical association with RAG endonuclease [88]. 
Most studies involving homing endonucleases have focused on targeted integration at a 
specific location in the genome in tandem with various read-out systems for determining 
both cleaved and uncleaved status of the break. One study utilized a chromosomally 
integrated I-SceI site besides a Tet operator array that was visualized by binding of a 
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Tet repressor-GFP fusion to study the recruitment of various repair factors at the site of 
DSB utilizing light microscopy in various mutant cell lines. A single I-SceI site integrated 
by chance close to an endogenous dhfr locus was studied, which showed that I-SceI-
induced homogenously stained region (HSR) breakdown leads to formation of double 
minutes and induction of various types of chromosomal rearrangements [89]. A study 
utilizing genetically modified mouse embryonic stem cells carrying two I-SceI sites in cis 
and non-repetitive region of the same chromosome separated by 9 kbp showed that in 
spite of a functional NHEJ machinery, some unusual joining intermediates are formed 
that severely affect the repair efficiency of these two distant DSBs, leading to a large 
spectra of mutagenic events [90]. Utilizing a similar approach, another group studied the 
effect of single and 2 DSBs induced by I-SceI to determine the junctional characteristics 
after the breaks induced were rejoined, inferring that NHEJ for repairing I-SceI-induced 
DSBs mainly results in small or no deletions[91]. Numerous other studies have utilized I-
SceI and other homing endonucleases for characterization of DNA repair pathways over 
the years[79-81, 92-94]. 
 
1.3.1 Homing Endonucleases 
Homing Endonucleases are proteins of < 40 kDa. The word “Homing” means the lateral 
transfer of an intervening sequence (either an intron or intein) to a homologous allele 
that lacks the sequence. This process is catalyzed by double stranded DNases that 
recognize and cleave the target allele, which itself is coded by an open reading frame 
(ORF) embedded within the mobile intervening sequence. 
They recognize long DNA target sites (14 - 40bp). The four main Homing Endonuclease 
families are: LAGLIDADG, GIY-YIG, His-Cys box and H-N-H [95]. Although most homing 
endonucleases share with restriction enzymes the ability to make a site-specific double-
strand break in the DNA target, they differ in structure, recognition properties, and 
genomic location. Homing endonucleases are named using conventions similar to those 
of restriction endonucleases with intron-encoded endonucleases containing the prefix, 
“I-”. Homing endonuclease recognition sites are extremely rare. For example, an 18 
base pair recognition sequence will occur only once in every 7 x 1010 base pairs of 
random sequence. This is equivalent to only one site in 20 mammalian-sized genomes 
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[80]. However, unlike standard restriction endonucleases, homing endonucleases 
tolerate some sequence degeneracy within their recognition sequence. As a result, their 
observed sequence specificity is typically in the range of 10-12 base pairs. Homing 
endonucleases do not have stringently-defined recognition sequences in the way that 
restriction enzymes do, i.e. single base changes do not abolish cleavage but reduce its 
efficiency to variable extents. The precise boundary of required bases is generally not 
known. 
 
1.3.2 I-SceI 
I-SceI is an intron-encoded site-specific homing endonuclease isolated from the 
mitochondria of Saccharomyces cerevisiae. I-SceI belongs to the LAGLIDADG homing 
endonuclease family, whose members cleave long DNA substrates (>14 bp) to generate 
four base 3’-overhangs [95]. LAGLIDADG endonucleases (see Figure 7) are either 
monomers, such as I-SceI, that are composed of two pseudosymmetric subdomains that 
recognize asymmetric substrates [96] or homodimers, such as I-CreI, that recognize 
palindromic or pseudopalindromic substrates [97]. The recognition sequence of I-SceI is 
an 18 bp non-palindromic sequence. The insertion of I-SceI recognition sites in the 
genomes of other organisms results in selective double-strand DNA cleavage at the 
inserted site, leaving the remainder of the genome intact. I-SceI stimulates more than 
1000 fold the frequency of recombination between a chromosomal locus containing the 
cleavage site and homologs located on exogenous DNA [98], making I-SceI an ideal 
choice for gene targeting studies and studying DNA repair pathways like non-
homologous end joining and HRR [99] [99-102] [103]. 
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Fig. 7: Structure of PI-SceI, a LAGLIDADG family member. Endonuclease domains 
are shown in blue with orange β-sheets showing DNA-binding saddle [95]. 
 
1.4.  Utilization of Transposons for study of DSB repair 
Most studies till date have focused on creating a single DSB or 2 DSBs by Homing 
endonucleases like I-SceI and studying aspects of DNA repair like recruitment of 
different proteins at these sites of breaks with kinetics of recruitment, uncovering repair 
pathways and their intermediates, monitoring the movement of open ends in the nuclear 
matrix, etc. We strived to differ from the above mentioned studies by introducing as 
many I-SceI sites as possible into the mammalian cell genome. Random integration of 
sites in the genome with only transfection (nucleofection) yielded only one or two 
integrations, determined with Southern blotting. Thus to achieve our aim, we opted for a 
Transposon-based system which allows us to integrate our sequence of interest at many 
locations in the genome randomly. 
 
1.4.1 Types of Transposable Elements  
Transposable elements (TE) are characteristic segments of DNA which show the 
distinctive ability to move and replicate within genomes [104, 105]. Two major classes of 
transposable elements are known; the first class involves retrotransposons that 
transpose replicatively within their host genomes by using RNA intermediates [106]. As 
a result, the donor element does not move but instead a copy is produced, using reverse 
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transcription, which inserts elsewhere in the genome. In contrast to retroviruses, 
retrotransposons lack a glycoprotein envelope gene, which prevents the retrotransposon 
from forming an infectious virus particle and thus prevents it from leaving the host cell. 
Different types of retrotransposons exist, like long interspersed elements (LINEs), short 
interspersed elements (SINEs) and long terminal repeats (LTR).  
Most of the repeat sequences, which comprise more than 50% of the human genome, 
are derived from retrotransposons. The L1 element consists of a 5` UTR, two ORFs 
encoding a RNA binding protein, an endonuclease, a reverse transcriptase and a 
3`UTR. Alu, the only active SINE in the human genome, is derived from the 7SL RNA, a 
cytoplasmic RNA which functions in protein secretion as a component of the signal 
recognition particle [107]. In mammals, the L1 and Alu elements were inserted into new 
genomic locations during evolution. These elements are often truncated and rearranged 
to form inactive copies of their progenitors. Such mutations, if advantageous or neutral, 
may contribute on one hand to protein variability and versatility but on the other hand, if 
disadvantageous, they can generate genetic diseases. 
The second class of transposable elements involves DNA transposons which move 
directly as DNA segments. DNA transposons are flanked by terminal inverted repeats 
(TIRs). The transposition is characterized by a “cut and paste mechanism” whereby the 
transposon is excised from the donor locus and reinserted randomly somewhere else in 
the genome. This process is catalyzed by the element-encoded transposase. The 
different classes of DNA transposons are divided into superfamilies. The following nine 
DNA transposon superfamilies are known in eukaryotes: CACTA, hobo/Activator/Tam3 
(hAT), Merlin/IS1016, Mutator, P-element (Drosophila), PIF/Harbinger, PiggyBac, 
Tc1/mariner, and Transib [108]. The different superfamilies are characterized by a 
superfamily-specific transposase core domain, which is different from those of other 
superfamilies. Furthermore, superfamilies differ in the presence and size of the target 
site duplication (TSD), a short direct repeat that is generated on both flanks of a 
transposable element upon insertion [109]. 
Transposons occupy about 45% of the human genome, whereby the DNA transposons 
account for about 2-4% and the retrotransposons about 41%.  Despite the fact that they 
make up such a significant fraction of the genome, no indication of DNA transposon 
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activity has been noticed in the human genome for the past 50 million years 
(International human genome sequencing consortium, Nature 2001).   
 
1.4.2 The Sleeping Beauty Transposon system 
Active DNA transposon systems are existent endogenously in invertebrates, but in 
vertebrates, they were inactivated millions of years ago. Since transposition offers 
unique advantages in experimental genome manipulation, efforts were made to 
generate active transposon systems in vertebrates.  
As part of these efforts, a TC1/mariner-type transposon found in fish genomes was 
reconstructed by eliminating different inactivating mutations from the transposase gene, 
like insertions, deletions and point mutations. For this purpose, phylogenetic data of 
different teleost fish species and comparative analysis of functional transposase 
domains were used. The phylogenetic data comprised a multiple sequence alignment of 
salmonid TE sequences from twelve fish species. Five highly conserved regions, located 
in the transposase gene, were found: a nuclear localization signal (NLS), a glycine rich 
motif and three segments in the C-terminal region including an amino acid triad DDE 
domain. In the first step of reactivating the salmonid transposase gene, the TE open 
reading frame (ORF) was restored by combining parts of two inactive TEs of Atlantic 
salmon and a single part of rainbow troat and removing the premature translational stop 
codons and frameshifts. In the second step, non-synonymous nucleotide substitutions of 
the consensus sequence were eliminated in order to rebuild putative functional protein 
domains. Simultaneously, a full length gene was synthesized which is equal to the 
consensus sequence. This reconstructed synthetic transposase gene and a 
nonautonomous salmonid-type element from Tanichthys albonubes, that carries the 
inverted repeats of the transposon substrate DNA, constitute the active transposon 
system, named Sleeping Beauty (SB). Members of the TC1/mariner superfamily of 
transposable elements are extraordinarily widespread in nature, ranging from single cell 
organisms to humans. Therefore the salmonid SB transposon is able to mediate 
transposition in different species like fish, mouse and human cells [110].  
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1.4.3 Structure of the Sleeping Beauty Element 
The SB transposon consists of a single gene encoding the transposase polypeptide, 
which is flanked by the inverted repeats (IRs) containing binding sites for the 
transposase. The SB transposon is nonautonomous and not able to transpose without 
an appropriate transposase encoding sequence. As long as transposons retain their IRs, 
the transposase can mobilize transposons in trans and can be physically separated from 
the transposon element. This gives the possibility to remove from the transposon the 
DNA segment coding for the transposase and insert other DNA sequences. The 
transposase binding sites of the SB element show a specific structure. Two binding sites 
are located at the ends of the 200-250 bp long inverted repeats and contain short 15-20 
bp direct repeats (DRs). This special organization of the whole region is termed IR/DRs. 
The left IR contains the HDR sequence motif which is similar to the 3’ half of the 
transposase binding sites.  
The transposase has an N-Terminal, bipartite, paired like DNA-binding domain 
containing the two helix-turn-helix motifs PAI and RED separated by a GRRR-AT hook 
motif to mediate DNA binding to the DRs. Furthermore, it contains a nuclear localization 
signal (NLS) flanked by phosphorylation target sites of casein kinase II, which serve as a 
checkpoint in the regulation of transposition. At the C-terminal site, the catalytic domain 
is located, characterized by the conserved amino acid triad DDE [111]. Within the 
catalytic domain of the transposase, a glycine rich motif is present, but its function is 
unknown. The transposase used in this work is a hyperactive variant of the original SB 
transposase. 
 
1.4.4 Mechanism of Transposition  
The “cut and paste” transposition process involving the excision of the DNA element 
from its DNA context and the reintegration into a different locus in the genome, can be 
divided into four major steps (Figure 8): 
In the first step, the transposase binds to the IRs of the transposon. The SB substrate 
recognition and transposition are highly specific. The SB transposase is able to 
distinguish its own substrate from a different substrate which differs in no more than two 
bps [112]. The specificity of DNA-binding is mediated by the PAI sub-domain of the 
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transposase through a base specific interaction. The 3’ part of the transposon binding 
site is recognized by a PAI sub-domain whereas the 5’ part is recognized by the RED 
sub-domain of the transposase. Furthermore, PAI binds to the HDR motif of the 
transposon and mediates interactions with other transposase units within the active 
tetramer. 
In the second step, the synaptic formation takes place, where the two ends of the 
transposon element are paired and held together by the transposase. This step serves 
as a checkpoint for the transposition, controlling whether all molecular requirements are 
fulfilled. During synaptic complex formation, the complete IRs with four transposase 
binding sites forms transposase tetramers. The HDR motif of the transposon serves as a 
transpositional enhancer. 
The third step, transposon excision, takes place when the synaptic complex formation is 
completed. The DDE catalytic sub-domain of the transposase catalyzes the cleavage at 
the ends of the SB element and generates overhangs of three nucleotides, GTC, at both 
ends of the transposon. The terminal nucleotides of the transposon which are left behind 
at the donor site, generate a three bp transposon “footprint” after NHEJ repair at the 
donor site. 
In the fourth step, reintegration of the transposon takes place, catalyzed by the DDE 
subunit of the transposase. Sleeping Beauty shows a random pattern of integration in 
the human genome [113]. It prefers TA dinucleotides as integration sites which occur 
approximately every 20 base pairs in vertebrate genomes. Palindromic AT-repeats: 
ATATATAT were found to surround the integration site. The 3’ ends of the excised 
transposon invade the target DNA molecule after the transposase has cleaved the TA 
dinucleotide target integration site. The TA target site is duplicated upon insertion. 
 
1.4.5 Integration activity of SB in human cells 
A two component assay was used to detect chromosomal integration events into the 
chromosomes of human HeLa cells [110]. Therefore two non autonomous transposon 
elements, the donor plasmid containing the neo selectable marker gene flanked by IRs 
and the helper plasmid expressing the transposase, were cotransfected in cultured 
vertebrate cells. The highest transposition rates were observed when the transposase 
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expressing plasmid was added in a ratio 1:10 dilution compared to the donor plasmid. If 
the ratio of the transposase is too high an effect called "overproduction inhibition" occurs 
which results in a decrease of transpositional activity. The number of cell clones 
resistant to the neomycin-analog drug G-418 served as the indicator for the integration 
and expression of the neoR transgene [114]. Further details are explained in the 
experimental strategy section. 
Introduction 
 21
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Mechanism of Sleeping Beauty Transposition. Yellow circle denotes 
Transposase. 
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1.5.  History of plasmid-based DNA repair assays 
Analysis of the kinetics of repair of IR-induced genomic DSBs remains the golden 
standard in the field. However, the assays used, e.g. pulsed field gel electrophoresis, 
comet assay etc., and the random distribution of DSBs in the genome, as well as their 
generation at different genomic sites in each individual cell, preclude precise 
characterization and analysis of the joining event. Despite great progress in recent 
years, key aspects regarding the function of DSB repair pathways await elucidation. 
Progress in this direction will depend profoundly on robust assays allowing the 
elucidation and characterization of the underlying molecular steps and the definition of 
parameters determining functional requirements. 
To overcome this limitation, assays were developed in which plasmid DNA appropriately 
digested in vitro using restriction endonucleases to generate DSBs with the desired 
ends is introduced using a spectrum of transfection methods into cells of different 
genetic background. Appropriately selected reporter genes allow quantification of repair 
efficiency, and plasmid rescue experiments offer means for analyzing the junctions 
generated. 
These assays have been used extensively and have been instrumental in the 
characterization of the junctions generated by NHEJ. Numerous studies carried out with 
repair proficient cells demonstrated that D-NHEJ is an efficient but error prone repair 
process. That it only rarely utilizes homology in the form of local microhomologies, and 
that it is associated with nucleotide loss or gain, which can at times be extensive [115]. 
Importantly, these studies also showed that in D-NHEJ deficient mutants end joining 
(presumably by B-NHEJ) generates junctions using similar basic rules, albeit with 
increased use of microhomology, which rises from a few percent in wild type to over 
30% in the mutant cells [116] [117] [118]. In addition, nucleotide deletions tend to be 
more frequent and larger extending to a few hundred base pairs.  
While these plasmid assays have been very consistent when analyzing the architecture 
of the junctions generated by different forms of NHEJ, they generated quite divergent 
results when the efficiency of rejoining in D-NHEJ mutants was analyzed. Thus, while a 
defect in the repair of IR induced genomic DSBs is a uniform observation of all available 
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studies with D-NHEJ mutants, several studies using plasmid assays show no reduction 
in the rejoining efficiency [115] [119] [120] [121] [122] [123] [124] [125]. Since other 
studies show a measurable reduction in rejoining efficiency in D-NHEJ mutants and 
occasionally even strong effects are reported [116] [126] [127] [128], it is not possible to 
attribute this difference to a fundamental generally applicable property of the plasmid 
assay. 
The spectrum of these divergent results masks the characterization and understanding 
of the components of DNA double strand break repair pathways in cells and has a direct 
bearing on human health, which makes it all the more imperative to solve this 
conundrum. 
Since both projects discussed here involve transfection of constructs as DNA repair 
substrates and integration of DNA constructs in the genome of mammalian cells along 
with transfection of constructs expressing various chimeric proteins, in the following 
paragraphs, we discuss the principles of transfection methods used and the different 
methods available. 
 
1.5.1 Transfection 
Transfection is a term used for non-viral methods of introduction foreign substances into 
the cells. Transfection of animal cells typically involves opening of transient pores in the 
cell membrane to allow the uptake of material. Application of recombinant DNA 
technology to genetically manipulate the spectrum of cellular functions of a cell requires 
a suitable high efficiency transformation system. A number of conventional gene transfer 
techniques are available for transforming eukaryotic and prokaryotic cells. 
These can be divided into three basic types: 
A. Chemical-based transfection: Involves use of calcium phosphate, liposome-mediated 
transfection using cationic lipids, DEAE-Dextran, Polyethylenimine, etc. 
B. Non-chemical methods: Electroporation, Nucleofection, Sono-poration, etc. 
C. Particle based methods: Gene gun technique, Magnetofection, etc. 
D. Viral methods utilizing viral transduction. 
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Since the transfection techniques utilized in this thesis are lipofection and nucleofection, 
a brief description of the methods is provided here. 
 
1.5.1.1.  Lipofection  
LipofectamineTM is a cationic lipid-mediated transfection reagent [129]. Cationic lipids 
are composed of a positively charged head group and one or two hydrocarbon chains. 
Negatively charged phosphate groups on DNA bind to the positively charged surface of 
the liposome forming the “transfection complex”, and the residual positive charge then 
presumably mediates binding to negatively charged sialic acid residues on the cell 
surfaces allowing the fusion of the liposome/nucleic acid complex into the cell 
membrane (see Figure 9). The transfection complex is thought to enter the cell through 
endocytosis, but the complex must escape the endosomal pathway and diffuse through 
the cytoplasm. It is generally believed that the transport of the nucleic acid into the 
nucleus happens when the nuclear membrane is broken down during cell division. 
 
 
 
 
Fig. 9: Representation of liposome-mediated transfection method. 
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1.5.1.2.  Nucleofection 
Nucleofection is a technique based on electroporation. ‘‘Electropermeabilization’’ or 
‘‘electrotransfection’’ or ‘‘electroinjection’’, as it is also called, is a technique where 
reversible electrical breakdown of cell membranes is associated with the change in 
permeability and sequestering of nucleic acids, proteins or antibodies through the cell 
membrane, utilizing brief, high intensity pulse(s) to create transient pores in the cell 
membrane. The survival of the electrically transfected cells is ensured by removal of the 
external electrical field, which leads to the resealing of the membrane electropores. 
Nucleofection/Nucleofector® technology is a specialized electroporation technique 
where a combination of electrical parameters with cell-type specific reagents allows the 
delivery of substances directly into the cell nucleus and the cytoplasm, thus allowing 
transfection in hard-to-transfect non-dividing and primary cells. 
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1.6.  Objectives 
The molecular analysis of DSB repair has benefited from assays allowing more precise 
substrate fate analysis. We focus our attention here to the various conflicting and 
intriguing results published to date about the effects of mutations of the principal 
components of D-NHEJ pathway on double strand break repair ability of the cells, 
studied principally utilizing DNA reporter substrates digested in vitro using restriction 
endonucleases to generate DSBs with the desired ends. These substrates were then 
introduced into the cells utilizing a myriad of transfection methods and the reporter 
system allowed quantification of efficiency of repair. Plasmid rescue experiments also 
allowed determining the spectrum of junctions generated after repair. Several studies 
over the years have reported little or no effect on DSB repair capacity of cells devoid of 
the core components of D-NHEJ pathway measured by various plasmid end joining 
assays in vivo. The spectrum of these divergent results masks the characterization and 
understanding of the components of DNA double strand break repair pathways in cells 
and has a direct bearing on human health, which made it all the more imperative to 
solve this conundrum. 
The objective of this project was to determine the reasons for these observed 
discrepancies in results obtained with plasmid end joining assays, which sometimes 
were in complete disagreement to the results obtained with standard DNA repair assays 
like pulsed field gel electrophoresis, comet assay, etc. We also hypothesized that these 
divergent results reflect methodological differences that affect important parameters of 
the plasmid rejoining reaction. Results obtained with a plasmid-based DNA repair assay 
[130] in various D-NHEJ mutants utilizing Lipofection and Nucleofection techniques are 
presented here. 
The second part of the thesis involves study of complex lesions utilizing homing 
endonuclease-based model systems. Energy deposition by ionizing radiation (IR) in 
cells takes place along the particle tracks in close vicinity and are not uniformly 
distributed in space. The distance between ionizations vary on a particle track but the 
distance between ionizations are known to be reduced along a track as the particle 
loses energy. Electrons are known to show this phenomenon and to form clustered 
lesions at the end of their tracks, which is referred to as the high LET component of a 
low LET radiation. These complex/clustered DSBs arising from these events are thought 
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to be the prime factor behind cell lethality with increasing LET. Repair of these lesions 
would require extensive processing leading to deletions and probably oncogenic 
transformation. 
The purpose of our study was to devise model systems which would allow us to study 
simple and complex types of DSBs that are potentially lethal for a living mammalian cell. 
It was also an aim to investigate whether the processing of single DSBs differs from 
complex/clustered types and to determine the outcome of repair of the same. Discussing 
DNA repair in the context of chromatin, a recent review from our group [34] explains that 
out of the three major repair pathways available to a cell, NHEJ requires the least 
chromatin modification for operating successfully, with single strand annealing (due to its 
search for homology) and homologous recombination (due to its template-based 
approach) requiring the most. With the switch in preferences for repair pathway choice 
moving from lower to higher eukaryotes, it was hypothesized that maintaining chromatin 
integrity has taken precedence in evolution over the restoration of local sequence 
integrity in higher eukaryotes. 
The present project tests the hypothesis that clustering of DSBs at distances affecting 
nucleosomal stability is highly lethal and mutagenic for the cell. In our experimental 
strategy, DSB clusters are induced in the genome of human tumor A549 cells through 
enzymatic restriction of I-SceI sites integrated at different combinations and at multiple 
sites using transposon technology. To address complexity, we generate constructs 
harboring one and two I-SceI sites separated by 200bp. To add another degree of 
complexity, we also generated a construct harboring the two I-SceI sites in incompatible 
orientations. The transposon-based vector used contains the neoR gene as a selectable 
marker and its integration at multiple sites is facilitated by co-expression of a hyperactive 
transposase artificially reactivated from the “Sleeping Beauty” transposon. The number 
of integration sites is measured in randomly selected G418 resistant clones using 
Southern blotting and sets are generated with clones harboring 1-20 integration sites for 
each DSB arrangement. These clones were then utilized to perform assays like 
clonogenic survival assays, determination of chromosomal aberrations, γ-H2AX foci 
determination, etc. for determining the cellular effects arising from these enzyme-
induced lesions. 
 
Experimental Design 
 28
1.7.  Experimental Design 
To evaluate DNA end joining in vivo, we employed a fast-readout plasmid-rejoining 
assay using the plasmid pEGFP-Pem1-Ad2, as described earlier [130]. The plasmid is a 
derivative of pEGFP-Pem1 (7,139 bp) that was generated by L. Li from pEGFP-N1 
(Clontech, Palo Alto, CA) by interrupting the enhanced green fluorescent protein (EGFP) 
sequence with the Pem1 intron. It was constructed by inserting the wild-type adenoviral 
major late mRNA leader sequence adenoviral exon 2 (Ad2) into the polylinker site within 
the Pem1 intron of pEGFP-Pem1 after appropriate modifications to generate HindIII and 
I-SceI cutting sites, as well as splice sites on both sides of Ad2. In this configuration, the 
EGFP gene is normally disrupted by the Ad2 exon and therefore transfection of 
supercoiled plasmid generates no EGFP signal. When Ad2 is removed before 
transfection, by digestion at both sides, either with HindIII or I-SceI, EGFP activity can 
be recovered if the transfected cell possesses end joining activity to re-circularize the 
linear plasmid. Partly digested plasmid that retains the Ad2 sequence generates no 
signal.  
In the experiments reported here, the pEGFP-Pem1-Ad2 plasmid was digested with 
HindIII to remove Ad2 and generate cohesive ends with 4-bp 5’ protruding single 
strands. Supercoiled pEGFP-Pem1 was used as a positive control to standardize the 
transfection and analysis conditions. The pDsRed2-N1 plasmid (Clontech) was 
cotransfected with either linearized pEGFP-Pem1-Ad2 or supercoiled pEGFP-Pem1 to 
evaluate the transfection efficiency utilizing Lipofection and Nucleofection. The ratio of 
GFP+ to Red+ cells was plotted as a function of the amount of GFP-Pem1 vector. The 
percentage of rejoining was then calculated as equivalent circular DNA over 
concentration of linear DNA transfected x 100%.  
All plasmids were prepared in XL-1 Blue bacteria and purified using CsCl/EtBr gradients. 
The HindIII linearized pEGFP-Pem1-Ad2 was purified by gel electrophoresis to remove 
the Ad2 fragment. Plasmid rejoining efficiency was tested in MEFs and CHO cells both 
proficient and deficient in D-NHEJ pathway components. 
Our experimental design for the second project involves creation or induction of simple 
and complex homing endonuclease-induced DNA double strand breaks. This was 
accomplished by stably integrating I-SceI homing endonuclease sites into the genome at 
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various sites in “simple” and “complex” orientations. The terms “simple” and “complex” 
denote the I-SceI sites in compatible and incompatible orientations to each other 
respectively. The constructs are designed bearing I-SceI sites in compatible and non-
compatible orientation separated by 200bp. Compatible ends are defined as 
overhanging sequences which are complementary at both I-SceI sites after restriction 
and the loss of the 200bp spacer. The term incompatible is defined here as overhanging 
DNA sequences exclusively formed when the 200 bp spacer is lost in the construct 
bearing reversely oriented I-SceI sites, where complementary sequences at the DNA 
ends are not available for direct rejoining.  
For punctuating the genome with I-SceI sites at various locations randomly, we utilized 
the Sleeping Beauty Transposon system developed by Ivics et al. [104, 105, 110-112, 
114, 131, 132], which functions by inducing global mutagenesis via non-homologous 
end joining (NHEJ) in the genome. The system utilizes two constructs, one called as the 
“Donor” plasmid and the other “helper” plasmid expressing the modified “hyperactive” 
variant of the Sleeping Beauty transposase. The donor plasmid is a construct in which 
our sequence of interest is cloned upstream of the NeoR gene and flanked on both sides 
by Inverted Repeats/Direct Repeats (IR/DRs), which are the recognition sequences of 
the Sleeping Beauty Transposase (Figure 8). The hyperactive version of the Sleeping 
Beauty Transposase cleaves the plasmid at the IR/DR sites, carries the sequence of 
interest along with the NeoR gene marker and integrates it randomly in the genome by a 
transposon-mediated cut-and-paste mechanism. We utilized two variants of I-SceI 
constructs for expression in vivo, one in which I-SceI is constitutively expressed, called 
as pCMV-I-SceI-3xNLS [92, 94, 102] and the other construct expressing a chimera of 
EGFP-I-SceI-GRLBD, which is inducible by addition of triamcinolone acetonide (TA) [82, 
89]. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Laboratory apparatus 
AI Filter       GE Healthcare, USA 
ÄKTA FPLCpurifier 10/100 UPC-900   GE Healthcare, Germany 
Avanti J-20XP      Beckman Coulter, USA 
Beckman Tabletop GS-6R centrifuge   Beckman Coulter, USA 
BioFuge (Fresco)      Thermo Scientific, Germany 
Cell culture “Herasafe” hood    Thermo Scientific, Germany 
Coulter Counter      Beckman Coulter, USA 
Electro-Transfer Unit     Bio-Rad, USA 
Express Pipet-Aid      BD Falcon, USA 
Flow Cytometer      Beckman Coulter, USA 
Heating unit       Peter Oehman, Germany 
Hybridizer HB-1000      UVP LLC, USA 
CO2 Incubator      Sanyo, Japan 
Magnetic Stirrer      Heidolph, Germany 
Inverted Microscope     Olympus, Japan 
Molecular Imager VersaDoc    Bio-Rad, USA 
Nanodrop       Thermo Scientific, Germany 
Overnight Culture Shaker      Infors, Germany 
Pasteur pipette      BD Falcon, USA 
Peristaltic pump      Ismatec, Switzerland 
pH Meter       InoLab, Germany 
Pipettes        Eppendorf, Germany 
Rocky Shaker      Peter Oehmen, Germany 
Roller drum       Bellco Biotechnology, USA 
SDS PAGE mini gels     Mini PROTEAN, Bio-Rad, USA 
Scintillation Counter      Beckman Coulter, USA 
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Thermo-mixer      Eppendorf 
Typhoon Scanner      GE Healthcare, USA 
Ultracentrifuge      Beckman Coulter, USA 
UV Spectrophotometer     Shimadzu Corp., Japan 
Vortexer (Vortex-Genie 2)     Scientific Industries, USA 
Water Bath       GFL Instruments, Germany 
Weighing Balance      Sartorius (BP110 S) 
X-ray machine (320KV)     GE Pantak, Germany 
2.1.2 Disposable elements 
0.2μm filter       Millipore, USA 
1.5 and 2 ml tubes      Eppendorf, Germany 
15 & 50 ml Centrifuge Tubes    BD Falcon, USA 
Cell Culture Dishes      Cell Star, USA 
Dounce homogenizer     KonTes, Kimble Chase, USA 
Flasks and beakers      Schott Duran, Germany 
Nitrocellulose membrane     Schleicher Schuell, Germany 
Nylon membrane      Roche, Germany 
Rainin Pipettes      Mettler Toledo, Germany 
PVDF membrane      GE Health care, USA 
Spinner Flask      Bellco, USA 
UV Cuvettes       Hellma, Germny 
Parafilm       Lab Depot Inc. USA 
 
2.1.3 Chemical reagents 
 
The chemicals used were of analytical grade 
 
Acrylamide-Bis-acrylamide (37:5.1)   Roth, Germany 
Albumin Bovine      Sigma-Aldrich, USA 
Bromophenol Blue      Sigma-Aldrich, USA 
DMEM       Sigma-Aldrich, USA 
dNTPs       Promega, USA 
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DTT        Roth, Germany 
EDTA        Roth, Germany 
Ethanol       Roth, Germany 
FCS/FBS       Gibco Life Sciences, USA 
Glycerol       Roth, Germany 
Glycine       Roth, Germany 
Grace’s Insect Medium     Gibco Life Sciences, USA 
Isopropanol       Roth, Germany 
KCl        Roth, Germany 
Lactalbumin hydrolysate     Sigma-Aldrich, USA 
Luria Broth       USB Corp, USA 
Luria Agar       USB Corp, USA 
McCoy’s5A       Sigma-Aldrich, USA 
MEM        Gibco Life Sciences, USA 
Methanol       Sigma-Aldrich, USA 
NaCl        Roth, Germany 
Non-Fat dry milk      Roth, Germany 
Nonidet P40       Roche, Germany 
Phusion Hot-Start High Fidely Polymerase  Finnzymes-NEB, USA 
Poly L-Lysine      Biochrom AG, Germany 
ProLong Gold Antifade solution    Invitrogen, USA. 
Propidium Iodide      Sigma-Aldrich, USA 
RNase       Sigma-Aldrich, USA 
TEMED       Roth, Germany  
TRIS Base       Roth, Germany 
Tris-HCL       Sigma-Aldrich, USA 
Triton X-100       Roth, Germany 
Trypsin       Biochrom, Germany  
Coommassie brilliant blue G-250    Serva, USA 
Tween 20       Roth, Germany 
 
Materials and Methods 
 33
2.1.4 Commercial kits and columns 
α-32P CTP       Perkin Elmer, USA 
Label IT CX Rhodamine Labeling kit   Mirus Bio, USA 
DNA cellulose resins     Sigma-Aldrich, Germany 
ECL Western Blotting Reagent    GE Healthcare, USA 
DNA Maxi-prep Kit      Qiagen, USA 
FlexiGene DNA Kit      Qiagen, USA 
Hi Load (26/60) SuperDex 200    GE Healthcare, USA 
HiTrapTM Heparin prepacked column   GE Healthcare, USA 
ProbeQuant G-50 Columns    GE Healthcare, USA 
Prime-It II Random Primer Labeling kit   Stratagene, USA. 
QuikHyb Hybridization Solution    Stratagene, USA 
QIAquick Nucleotide removal Kit    Qiagen, Germany 
Salmon Sperm DNA     Roche, Germany 
Materials and Methods 
 34
 
2.2 Methods 
2.2.1 Cell Culture and chemicals 
For experiments, we used mouse embryo fibroblasts (MEFs) from p53-/- as well as LIG4-
/-/p53-/- animals [133]. Chinese hamster cells (CHO9) were used as a repair proficient 
control to the xrs-6 mutant [134], which is defective in Ku80, and the XR-C1-3 mutant, 
which is defective in DNA-PKcs (a kind gift from Dr. M. Zdzienicka). xrs-6/KU80, is a 
corrected cell line generated by transfecting xrs-6 with the human KU80 under the 
control of the Rous sarcoma virus long terminal repeat promoter [135]. MEFs were 
maintained in D-MEM supplemented with 10% fetal calf serum (FCS). CHO cells were 
cultured in McCoy’s 5A medium supplemented with 10% FCS. Propidium iodide (40 
µg/ml) was used for staining cells for Flow Cytometry (Beckman Coulter Epics XL-MCL).  
 
2.2.2 In vivo plasmid DNA end joining 
For Nucleofection, the appropriate plasmids were transfected using the MEF1 
NucleofectorR kit in the NucleofectorR device (Lonza) according to the instructions of the 
manufacturer. Typically, a suspension of 2 x 106 cells was transfected by Nucleofection 
with 0.2 µg pEGFP-Pem1, or HindIII linearized pEGFP-Pem1-Ad2 substrate, together 
with 0.2 µg of the transfection-efficiency marker pDsRed2-N1.  
In case of Lipofection, increasing concentrations from 0.05 µg of pEGFP-Pem1 or 
HindIII linearized pEGFP-Pem1-Ad2 plasmids with 2 µg of pDsRed2-N1 were 
transfected in near confluent exponentially growing cells in 60 mm dishes according to 
the manufacturer’s protocol. Green (EGFP) and Red (RFP) fluorescence were 
measured by flow cytometry 24 hours later. For this purpose, cells were trypsinized and 
resuspended in fresh growth medium at 106 per ml.  
Analysis was carried out in a Beckman Coulter Epics XL-MCL flow cytometer equipped 
with an argon ion laser emitting at 488 nm. Red fluorescence was collected at 540 nm 
with 740 V PMT gain, whereas green fluorescence at 490 nm with 490V PMT gain. 
Electronic compensation was 12.8% of green signal for red and 6.7% of red signal for 
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green. Transfection with supercoiled pEGFP-Pem1 was used to calibrate the system. To 
include the transfection efficiency in the calculation of percent rejoining, the 
EGFP+/Red+ ratio was calculated and compared between treated and non-treated cells. 
To calculate the percent rejoining of the linearized GFP plasmid, the GFP+/Red+ ratio 
obtained from various concentrations of NHEJ substrate was converted to an equivalent 
amount of circular GFP plasmid by extrapolating the points back on the curve obtained 
from the ratio of circular GFP+/Red+ cells. The percentage of rejoining was then 
calculated as equivalent circular DNA over concentration of linear DNA transfected x 
100%.  This method was used to calculate the rejoining efficiency of all cells used in all 
experiments carried out.  The results were confirmed in X-Y independent experiments. 
 
2.2.3 Plasmid preparation and CX-Rhodamine labeling of plasmid DNA 
Plasmid DNA was prepared by culturing green fluorescent protein (EGFP)-expressing 
plasmid (pEGFP-Pem1-AD2) containing bacteria overnight and using CsCl Density 
Gradient protocol for the large-scale purification of the plasmid DNA.  Plasmid purity was 
confirmed by Agarose gel electrophoresis, spectrofluorometrically and 
spectrophotometrically.  The day prior to transfection experiments, 10µg of circular 
plasmid DNA encoding GFP was labeled with CX-Rhodamine using a Mirus Label IT 
Tracker CX-Rhodamine kit as per the manufacturers’ instructions (Mirus, Madison, WI).  
Briefly, Rhodamine reagent was incubated with plasmid DNA (at a ratio of 0.75:1) at 
37ºC for 90 minutes and precipitated using 100% ethanol and 5M NaCl. To confirm 
plasmid labeling, absorbance was read at 576 nm (the appropriate wavelength for CX-
Rhodamine) and found to be 0.09 for labeled plasmid compared to 0.0 for unlabeled 
plasmid when using equivalent quantities of DNA (as determined by absorbance at 260 
nm). Successful plasmid labeling was also confirmed by spectrofluorimetric analysis and 
dilutions of labeled DNA were spotted onto glass slide and visualized under 
fluorescence microscope Leica DMI 6000 (Leica Microsystems). 
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2.2.4 Immunofluorescence, confocal microscopy and image analysis 
For immunofluorescence experiments, sterile coverslips in 35 mm dishes were coated 
with Poly L-Lysine (Biochrom AG, final concentration 0.01 mg/mL) the night before and 
cells were seeded as described above. In preparation for fixation media was aspirated 
and cells washed once with PBS (pH 7.4). Then, 2 ml of 2% Paraformaldehyde (PFA) 
was added for 15 min at room temperature (RT). PFA was aspirated and cells were 
washed with PBS. Cells were permeabilized with 2 ml solution P (100mM Tris, pH 7.4, 
50mM EDTA, 0.5% Triton X-100) for 10 min at RT. After a PBS wash, 1 to 2 ml of DAPI 
solution (Sigma Aldrich, 25 ng/ml working concentration) was added for 5 min at RT. 
After three PBS washes coverslips were mounted on slides using 15 µL anti-fade 
solution. Slides were stored in the dark before analysis using a Leica TCS SP5 Confocal 
microscope. 
Sequential scans at 0.5 µm steps were carried out with a 63X (N.A. 1.4) oil immersion 
Leica Objective for DAPI – GFP – CX-Rhodamine and DIC. For all images, a resolution 
of 512 x 512 and a pixel size of 240.74 nm X 240.74 nm were selected. For detection 
and measurement of DAPI, a laser diode of 405 nm was used at 40% power output was 
used for excitation. Fluorescence was collected at 410 – 550 nm using a smart gain of 
800 V and a smart offset of -2.0%. For detection and measurement of expressed GFP, 
an Argon laser at 488 nm and 25% power output was used for excitation. Fluorescence 
was detected between 495 – 550 nm using a smart gain of 750 V and a smart offset of -
5.0%. For the detection and measurement of CX-Rhodamine-labeled plasmid DNA, a 
laser diode at 461 nm and 25% power output was used for excitation. Fluorescence was 
detected between 570 – 650 nm using a smart gain of 950 V and a smart offset of -
5.0%. The last channel in the sequential scan was the transmission channel generating 
the DIC (Differential Interference Contrast) images of the cells. For the transmission 
channel, a 488 Laser was utilized with the laser intensity set at 25% using a smart gain 
of 350V and a smart offset of 0%.  
The statistical analysis of data obtained for the signal intensities of CX-Rhodamine-
labeled plasmid DNA was carried out using the Leica Application SuiteTM and Imaris® 
Image Processing Software. 
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2.2.5 Nuclease inhibitor experiments 
Triammonium salt of Aurintricarboxylic acid or ATA was dissolved in Milli-Q water 
(Millipore Corporation) and filtered with a 0.2 µM syringe filter (MinisartR Sartorius). It 
was used at a final concentration of 100nM to treat LIG4 and DNAPKcs mutant as well 
as wild type cells. 
 
2.2.6 Plasmid preparation 
Supercoiled plasmids were prepared using CsCl/EtBr gradients or a Qiagen Midi 
Plasmid purification kit. For CsCl/EtBr gradients, a 1 liter culture of plasmid-transformed 
E.coli was grown overnight and collected by centrifugation for 30 minutes at 1300g, 4°C. 
The pellet was resuspended in 10 ml Sucrose/Tris/EDTA solution and 2 ml of freshly 
prepared lysozyme was added and gently mixed. Cells were incubated for 30 minutes at 
room temperature and then 4 ml Triton lysis mix was added and culture was incubated 
at 37°C. Subsequently, lysates were centrifuged for 1 hour at 25,000 rpm (48,400g) in a 
Beckman JA25.50 rotor. Supernatant was removed and volume determined to add 0.95 
g cesium chloride per ml while making sure that it was completely dissolved. Then 0.1 
ml of 10 mg/ml EtBr solution was added per ml supernatant. Mixture was centrifuged for 
20 min in a Beckman JA 25.50 rotor at 7.000 rpm to remove protein and debris. Then it 
was transferred to an ultracentrifuge tube (Beckman: 4.2 ml, 6.3 ml or 8 ml) and 
centrifuged for 16 hours at 20°C in an ultracentrifuge (Beckman Optima Max) in a near 
vertical rotor MLN80 at 70,000 rpm (240,000g). Subsequently, the lower band was 
removed that contained the supercoiled plasmid and was transferred to another 4.2 ml 
ultracentrifuge tube. CsCl/TE solution containing 0.2 mg/ml EtBr was added to fill the 
tube, which was centrifuged again as described above. The lower band was removed 
and extracted with 1:1 phenol/chloroform twice and precipitated with ethanol overnight at 
–20°C. Pellet was extracted once more with phenol/chloroform and precipitated with 
ethanol. The resulting pellet was dissolved in TE buffer and followed by dialysis and 
concentration determination.  
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2.2.7 Methodology to determine percent rejoining in the plasmid 
rejoining assay 
GFP-Pem1-Ad2 was prepared with the above mentioned protocol and linearized by 
digestion with Hind III and purified by gel electrophoresis. Plasmid rejoining was tested 
in LIG4-/-/p53-/-mouse embryo fibroblasts. The appropriate plasmids were transfected in 
these cells using the Lonza Nucleofector and kit-MEF1 according to the instructions of 
the manufacturer. Transfection and analysis conditions were optimized using GFP-
Pem1 or pDsRed2-N1, alone or in combination. Typically 2x106 cells, in suspension, 
were transfected by electroporation with 0.2 µg GFP-Pem1, or Hind III linearized GFP-
Pem1-Ad2 substrate, together with 0.2 µg of the transfection-efficiency marker 
pDsRed2-N1. Green (EGFP) and Red (DsRed) fluorescence were measured by flow 
cytometry 24 or 48h later. For this purpose, cells were trypsinized and resuspended in 
fresh growth medium at 106 per ml. Analysis was carried out in a Beckman Coulter Epics 
XL-MCL flow cytometer equipped with an argon ion laser emitting at 488 nm. Red 
fluorescence was collected at 540 nm and 740 V PMT gains, while green fluorescence 
at 490 nm and 490V PMT gain. Electronic compensation was 12.8% of green signal for 
red and 6.7% of red signal for green. For calibration purposes and as standard to 
calculate rejoining efficiency, we used supercoiled GFP-Pem1 plasmid. Percent 
rejoining was calculated by dividing the signal generated from a given amount of 
linearized GFP-Pem1-AD2 by the signal generated from the same amount of 
supercoiled GFP-Pem1. Equal signal is defined as 100% rejoining as it will require 
circularization of all transfected linear GFP-Pem1-AD2; half signal is then equivalent to 
50% rejoining etc. In order to include the transfection efficiency in the calculation of 
percent rejoining the EGFP+/dsRed+ ratio was calculated first and then compared 
between the linear and the circular plasmid, as indicated above. There was an 
approximately linear increase in the EGFP signal with increasing amount of DNA in the 
range of concentrations employed. Results shown here have been confirmed in three or 
more independent experiments.  
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2.2.8 Tissue culture  
Tissue culture was performed in Sanyo MCO-18 O2/CO2 incubator at 37°C with 5% CO2 
(Sanyo). A549 cells were maintained in McCoy’s 5A medium (M4892, Sigma-Aldrich) 
supplemented with 10% fetal bovine serum (FBS) (S0615, Biochrom AG).  
Cells were grown in 100 ml tissue culture dishes (664160, CELLSTAR) with 15ml growth 
media. Exponentially growing cells were passaged every 3 days while avoiding 
confluency levels above 80%. For passage, medium was removed and cells were rinsed 
with ice-cold PBS. Cells were rinsed with 5 ml Trypsin-EDTA solution and incubated for 
5 min at 37°C. Detached cells were resuspended in 10 ml cold media supplemented 
with 10% FBS.  Single cell suspensions were obtained by passing cells through the 
Pasteur pipette. Cells were counted and appropriate numbers of cells were further 
incubated for experiments or for subculture. When frozen cells were taken to subculture, 
they were passed at least 2 times before being used in experiments. Cells were 
discarded after about 50 passages, since their genomic stability could not be 
guaranteed. 
2.2.8.1 Drug treatments 
Caffeine (C8960 Sigma-Aldrich) was dissolved in Milli-Q water (Z00QSV001, Millipore, 
18.2 MΩ·cm at 25°C) to prepare a 200mM stock solution. The solution was sterilized by 
passing through a 0.22μm filter and stored in RT. 4mM caffeine was used as the 
working concentration.  
2.2.8.2 Cell synchronization 
Cell populations enriched in G1 or G2 cells were obtained by centrifugal elutriation. 
Briefly, 1 million cells were seeded in 15 ml growth media supplemented with 10% FBS 
in 100 mm dishes. At least, 40 dishes were prepared for each elutriation. After 48 h, 
cells were washed, trypsinized, suspended in the fresh growth medium supplemented 
with 10% FBS and counted. About 140 million exponentially growing cells could be 
collected for elutriation. Cells were loaded into an elutriation rotor (Avanti J-20 XP, 
BECKMAN COULTER). Fractions were collected by gradually reducing the rotor speed. 
Cell cycle analysis was carried out by flow cytometry.  
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2.2.8.3 Ionizing radiation (IR) 
Cells were exposed to 320 kV X-rays with a 1.65 Al filter (GE-Healthcare). The dose rate 
was about 2 Gy/min. An even radiation was ensured by rotating the radiation table. Cells 
were returned to the incubator immediately after IR.  
2.2.8.4 Clonogenic survival assay after IR-induced DSBs 
For the clonogenic survival assay, wild type A549 cells along with clones bearing pairs 
of I-SceI sites were irradiated with 4, 8 and 12 Gy of X-rays, trypsinized immediately and 
plated in multiples with variable cell numbers according to the dose of radiation 
delivered. The cells were allowed to grow for 14 days and then stained for counting 
colonies.  
2.2.8.5 Clonogenic survival assay after I-SceI-induced DSBs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Flowchart of the two protocols used for survival assay. 
 
A similar protocol was employed for colony formation assay with pCMV-I-SceI-3xNLS 
construct, where 2 Mio. cells were transfected with 2µg of the construct utilizing 
nucleofection. 24 hours post transfection, the cells were trypsinized and plated in 
duplicates of 100 and 200 cells. The cells were then allowed to form colonies for the 
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next 10-12 days, after which they were stained with crystal violet stain and counted (see 
Figure 10). 
2.2.9 Flow cytometry 
2.2.9.1 Cell cycle analysis by flow cytometry 
Propidium iodide binds to DNA proportional to its mass. Cell cycle distribution was 
assessed by measuring Propidium iodide (PI) fluorescence on a flow cytometer. Cells 
were washed with cold PBS and trypsinized at 37°C for 5 min. Single cell suspensions 
were prepared in 5ml cold fresh media. About 1 million cells were collected and 
centrifuged at 1500 RPM, 4°C for 5 min. The cell pellets were washed with cold PBS 
and fixed in 70% ethanol at -20°C overnight. Supernatant was removed by centrifugation 
at 1500 RPM for 5 min. Pellets were washed with cold PBS and incubated in PBS 
containing PI (40 μg/ml) (81845, Sigma-Aldrich) and RNase (62 μg/ml) (R4875, Sigma-
Aldrich) at 37°C for 30 min in dark. Samples were measured on Epics XL MCL flow 
cytometer (Beckman Coulter) according to pre-established protocols. 20,000 cells per 
sample were counted and the single cell population was gated to obtain standard 
histograms. Histogram files (*.HST) were generated by counting the frequency of the 
cell with same PI signal intensity.  
The fractions of cells in the different phases of the cell cycle were calculated using the 
Wincycle® software. HST files were loaded into the Wincycle®. The parameter “S-phase 
growing order” was carefully chosen between 0, 1 or 2, until the prediction model fitted 
the histogram shape. Cell cycle distributions were automatically calculated. G2 arrest 
kinetics was obtained by plotting the G2 fraction as a function of time after IR. 
2.2.9.2 Bivariate flow cytometry 
Bivariate flow cytometry was used to simultaneously measure DNA content and the 
levels of proteins of interest, e.g. phosphorylation of Histone 3 at serine 10 (H3-pS10). 
Briefly, 0.6-0.8 million cells were prepared as single cell suspension in cold fresh media. 
After centrifugation at 1500 RPM, the cell pellets were washed with cold PBS and fixed 
in 70% ethanol at -20°C overnight. Supernatants were removed by centrifugation at 
1500 RPM for 5 min. Cells were further permeabilized in 2ml permeabilization solution 
(PBS + 0.25% Triton X-100) on ice for 15 min. Supernatants were removed by 
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centrifugation at 1500 RPM and the pellets were washed with cold PBS. Cells were 
blocked in blocking buffer (PBS + 0.05% Tween-20 + 1% BSA (8076.2, Roth)) at RT for 
45 min in the dark with gentle agitation. Primary antibody H3-pS10 (06-570, upstate) 
was diluted 1:150 in blocking buffer. After centrifugation at 1500 RPM for 5 min, the 
pellets were suspended in 100 µl diluted primary antibody and incubated for 2 h at RT in 
the dark with gentle agitation. The primary antibody was diluted in 5ml PBS and the cells 
were washed 3 times with PBS. Secondary antibodies, such as Mouse IgG-FITC 
(F0257, Sigma), Rabbit IgG-FITC (AP307F, Chemicon), were diluted in blocking buffer 
(1:200). Cell pellets were incubated with 100 µl conjugated secondary antibody for 90 
min at RT in the dark. Secondary antibodies were removed by diluting in 5ml PBS and 
washing with PBS for three times. Cells were then incubated with PI plus RNase at 37°C 
for 30 min in the dark before measuring on a flow cytometer. Totally 20,000 cells were 
measured. Proper gating was applied to detect H3-pS10 positive cells and to calculate 
their fraction in the total population. Compensation was applied when necessary (for 
details, see Appendix 1 and 2). 
 
2.2.10 Electrophoresis and Immunoblotting 
2.2.10.1 Cell extracts preparation and protein concentration determination 
Cells were collected by trypsinization and washed once with cold PBS and then washed 
once with hypotonic buffer. Pellet was resuspended in three packed cell volume of 
hypotonic buffer (see Appendix 4). The cells are lysed by three times freezing at -80ºC 
or liquid Nitrogen and thawing at 37ºC. Subsequently, the concentration of KCl was 
adjusted to 500mM. Incubate the mixture at 4ºC for 30 min on a rotating platform. 
Centrifuge mixture at 14,000 rpm at 4ºC for 40 min, remove supernatant and dialyze. 
After dialysis, centrifuge at 13.000 rpm for 20 min. The supernatant is WCE. 
2.2.10.2 Electrophoresis  
20 μg whole cell extract was mixed with 2x SDS-PAGE loading buffer. Samples were 
denatured at 95°C for 5 min and cooled down on ice for 5 min.  They were centrifuged at 
3000 RPM for 15 sec before loading. SDS-PAGE mini gels were cast (165-8000, Bio-
Rad) according to the instructions of the manufacturer. Proteins were resolved in gels 
with different concentrations according to their sizes; for example 15% gel for proteins 
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smaller than 50 kDa, 12% for proteins between 50-100 kDa, 10% for proteins between 
100-200 kDa, and 8% for proteins larger than 200 kDa. Samples were loaded and run at 
constant voltage (150 V) for 1.5 h at RT. 
2.2.10.3 Immunoblotting/Western Blotting 
After the electrophoresis, the gels were removed from the cassette and briefly rinsed 
with MQ water. PVDF membranes (RPN303F, GE Healthcare) and the blotting paper 
(GB004 Whatman) were cut to the desired size. PVDF membranes were pre-soaked in 
100% methanol for 1 min and rinsed in MQ water for 15 min. PVDF membranes, blotting 
paper and the transfer unit sponge were equilibrated in 1x transfer buffer (Glycine 
200mM (3908.2, Roth), Tris-HCl 25mM (4855.2 Roth), 10% Methanol (32205, Sigma-
Aldrich)) at 4°C for at least 30 min. The Gel, blotting papers, sponge and PVDF 
membrane were assembled and loaded into an electro-transfer unit (170-3930, Bio-Rad) 
according to the instructions of the manufacturer. Wet electro-transfers were run at 100 
V, 0°C for 1 h.  
After completion of the transfer, the unit was disassembled and the side of the 
membrane on which proteins were transferred was marked. PVDF membranes were 
briefly rinsed with PBST (PBS + 0.05% Tween-20) and blocked in blocking buffer (PBS 
+ 0.05% Tween-20 + 5% milk (T145.2, Roth) at RT for 1h with gentle agitation. Primary 
antibodies, for instance GFP for I-SceI (Abcam) 1:100, GAPDH (Mab374, CHEMICON), 
1:20,000. Membranes were incubated with primary antibodies at 4°C overnight with 
gentle agitation. The secondary antibodies, such as mouse IgG-HRP (7076, Cell 
Signaling), rabbit IgG-HRP (7074, Cell Signaling) were diluted 1:2000 in blocking buffer. 
After removing primary antibodies and washing with PBST (3 x 10 min), membranes 
were incubated with secondary antibodies at RT for 1 h. After washing with PBST (3 x 
10 min), the membranes were ready for development. The ECL developing solution 
(RPN2132, GE Healthcare) was prepared according to the instructions of the 
manufacturer and evenly distributed on the side of the membrane on which the proteins 
were transferred. After 1 min incubation at RT in the dark, images were obtained using 
the molecular imager VersaDoc MP 4000 System (170-8640, Bio-Rad). 
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2.2.11 Immunofluorescence and data analysis  
2.2.11.1 Confocal microscopy 
Sterilized cover slips (2 mm x 2 mm, 8404, Invitrogen) were incubated in 1 mg/ml poly-L-
lysine (L7240, Biochrom) solution for 1 h. Solution was removed and cover slips were 
stored at 4°C in the dark. Cells were plated with 2 ml growth medium in a 35 mm dish 
with poly-L-lysine coated cover slips. At each time point, growth media were removed, 
cells were washed in cold PBS 3 times and fixed in 2% Paraformaldehyde (PFA, 76240, 
Fluka) for 15 min at RT. PFA was removed and cells were washed 3 times with PBS. 
Cells were permeabilized in P-solution (100mM Tris pH7.4, 50mM EDTA, 0.5% Triton X-
100) for 10 min at RT. After washing 3 times with PBS, cells were blocked in the PBG 
solution (0.2% Gelatin, 0.5% BSA in PBS) at 4°C overnight.  
Primary antibodies, such as γ–H2AX were diluted 1:300 in PBG. 100 μl diluted primary 
antibodies were dispensed on parafilm (52858-032-CS, The Lab Depot, Inc.). The cover 
slips were mounted on top of the solution containing the primary antibodies. After 
incubating at RT for 2 h in the dark, slides were returned to the dishes and washed with 
PBST (PBS + 0.05% Tween 20) at RT 3 x 10 min. Conjugated secondary antibodies, 
such as Alexa488 mouse IgG (A11001, Invitrogen), Alexa568 mouse IgG (A11004, 
Invitrogen) were diluted in PBG 1:400. Slides were incubated with 100μl secondary 
antibody solution at RT for 1h in the dark. After 3 washes with PBST, cells were 
counterstained with 100ng/ml DAPI (Invitrogen) at RT for 5 min. The cover slips were 
washed 3 times with PBS and mounted on slides with 15μl ProLong Antifade Mounting 
Media (P-7481, Invitrogen). The slides were kept in the dark at RT and allowed to 
solidify for 48 h before analysis. 
Scanning of the slides was carried out on a Leica TCS SP5 confocal microscope. For 
each slide, at least 5 fields were scanned (about 150 nuclei). Resolution was set at 1024 
x 1024 and the zoom factor at 1.2. Bidirectional scans were applied to avoid bleaching 
of the fluorophore. Due to the differences in foci formation patterns, different proteins 
required different scanning parameters, such as laser intensity, PMT voltage, Smart 
Gain offset, filter spectrum range, etc. LIF files were generated after each scan, which 
were used for foci quantification using the Imaris® software (see below). TIFF Images 
shown in the text were obtained from the maximum intensity projection of the field 
scanned.  
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2.2.11.2 Foci scoring 
Foci numbers were enumerated using Imaris® (Imaris 6.0; Bitplane). At least 150 target 
nuclei were scored. The LIF files were loaded onto Imaris using default settings. “Bright 
dots” with a size larger than 0.5 µm and intensity above the threshold value (between 
17–21) were confirmed as foci. Foci were grouped in each nucleus, and the number of 
foci per nucleus was obtained. In some cases, the mean number of foci per nucleus was 
calculated from data obtained by analyzing many nuclei (for details, see Appendix 3). 
For data analysis, Microsoft Excel 2003® was used. 
2.2.12 Live cell imaging 
Live-cell imaging technique provides critical insights into the fundamental nature of 
cellular and tissue functions. Studies of cellular dynamics and cell physiology require live 
observation over time. For successful live cell imaging, the environment provided to the 
cells under the microscope is of utmost importance. The cells are also required to be 
plated in dishes or cell chambers with coverslip bottoms. The requirement for 
maintaining the cells at 5% CO2 during the span of investigation could be avoided by 
using HEPES buffered medium (L-15 Leibovitz medium) which does not require a 
controlled atmosphere, but suitability of the medium for the cells should be determined 
before. Cellular function is also exquisitely sensitive to temperature, hence objective and 
stage warmers are used. Heating of both the dish and the objective prevents 
temperature gradients across the dish. In live cell imaging experiments, instability of Z-
positioning happens over time. This focus drift is nearly always due to thermal 
expansion that occurs due to a temperature gradient. That is why both a stage warmer 
and an objective heater are used when z-stability is required for an experiment. Figure 
11 represents a schematic illustration of basic live cell imaging equipment.  
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Fig. 11: Representation of a typical setup of a live cell imaging experiment. Image 
courtesy: Nikon microscopy. 
For the experiment, the construct expressing EGFP-53BP1 was transfected using 
Nucleofector technology and the cells were directly plated in 3-well culture chambers. 
The cells were maintained in L-15 Leibovitz medium and 24 hours post transfection, 
pCMV-I-SceI-3xNLS was transfected using Lipofectamine 2000 reagent to the cells (to 
prevent cell lethality owing to trypsinization and electroporation for two consecutive 
days). For measurement of foci kinetics, a 63x Leica oil immersion objective was used 
with a numerical aperture of 1.3 and a zoom factor of 1.2. For measuring EGFP, 488 nm 
Argon laser was utilized with photomultiplier tube (PMT) setting in the range of 495-600 
nm. For DAPI channel, a 405 nm Laser diode was utilized with a PMT setting of 410-550 
nm range. Up to 5 field per well were tracked for the next 24 hours at an interval of 20 
min and the fields were selected to accommodate a number of green cells per view. 
Controls included 1 Gy X-ray irradiated samples, cells transfected with only EGFP-
53BP1 construct and untreated cells. 
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2.2.13 Cytogenetic assays 
The experiments are designed in such a way that DSB induction and repair are studied 
through their transformation to chromosome breaks that can be visualized by 
cytogenetic approaches in the G2 and M-phases of the cell cycle. The assay allows 
measurement in specific phases of the cell cycle and at very low radiation doses, which 
is not easily possible with other techniques of DSB repair such as PFGE, the comet 
assay etc. 
2.2.13.1 Assay to study the kinetics of G2-chromosome breaks at 
metaphase  
Exponentially growing cell cultures were either irradiated with 1Gy X-rays or transfected 
with I-SceI expression construct. Following irradiation and 24 hours post transfection, 
Colcemid was added for the duration of 4 hours. Cells were trypsinized, treated with 
hypotonic solution (75mM KCl) for 10 minutes at room temperature (RT) and fixed in 
Carnoy’s fixative (3X). The fixed cells were dropped on clean glass slide and stained 
with 3% Giemsa stain prepared in Sorenson’s buffer. For each experimental point about 
50 metaphases were scored for chromatid damage from three independent 
experiments. Standard criteria were used for scoring. During scoring, chromatid breaks 
and gaps were considered, the latter only when longer than the chromatid width. The 
chromosome exchanges were counted as two chromatid breaks. Bright field microscopy 
(Olympus, Japan) was employed to facilitate scoring.  
2.2.14 Premature chromosome condensation (PCCs) 
To study the influence of G2 checkpoint on chromosome break repair kinetics, 
exponentially growing cell cultures were irradiated with 1 or 2Gy X-rays (positive control) 
or transfected with I-SceI expression construct. 24 hours post transfection and 1 to 4 
hours post irradiation, 50nM Calyculin A was added for 45 minutes before harvesting the 
respective time point to induce PCCs. This time for Calyculin A treatment was 
considered in the repair time. Cells were harvested and prepared for cytogenetic 
analysis in a similar way as for the metaphases. About 50 G2-PCCs were scored for 
each experimental point from three independent experiments. During scoring excess 
PCC fragments were considered. The chromosome exchanges were counted as two 
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chromatid breaks. Bright field microscopy (Olympus, Japan) was employed to facilitate 
scoring. 
2.2.14.1 G2-PCC of cells after treatment with β-AraA 
To visualize the homing endonuclease-induced DSBs and to prevent their repair, cells 
were treated with the nucleotide analog β-AraA, which is known to inhibit DNA 
synthesis[136, 137]. 500µm β-AraA was administered to the transfected cells (24h post 
transfection) one hour prior to the addition of TA. Colcemid was added one hour after TA 
for two and a half hours. 30 min prior to collection, Calyculin A was added to the cells. 
The induction of chromosomal breaks by β-AraA is known, when it is added during DNA 
synthesis (S Phase) for a long period. We added β-AraA for a maximum of four hours so 
that the cells undergoing DNA synthesis while being treated with β-AraA are not scored 
in the G2-PCC. The following steps were as mentioned above. Untransfected cells 
treated with β-AraA served as a control.  
The dishes prepared for irradiation were treated with β-AraA 1h prior to irradiation. Two 
hours post irradiation, Colcemid was added and finally Calyculin A was added for 30min 
before fixation (Fig. 12). The cells were then fixed in Fixative (3:1 Methanol: Acetic 
Acid). Metaphase spreads were prepared and stained in 10% Giemsa in 1x Sörensens 
buffer for 15min. 
  
 
 
 
 
 
 
Fig. 12: Flowcharts of the protocols used to induce G2-PCC with ß-AraA and 
Hypertonic treatment. Protocol 1 shows cells treated with β -AraA before irradiation and 
transfection. Protocol 2 shows the steps used for hypertonic treatment of transfected and 
irradiated cells. 
Materials and Methods 
 49
 
2.2.14.2 G2-PCC of cells after hypertonic solution treatment 
pEGFP-I-SceI-GR transfected cells (24h post transfection) along with X-ray irradiated 
controls were treated with hypertonic solution for 20min (500mM NaCl in PBS) 1.5 hours 
after addition of the drug TA or after irradiation. After 20 min, hypertonic solution was 
removed and colcemid was added for 2 hours. Calyculin A was added 30 min prior to 
collection of cells. The cells were then trypsinized, centrifuged, medium was removed 
and the pellet was dissolved in the remaining 1ml of Media. 10ml of hypotonic solution 
(75mM of KCl) was added for 10 min at room temperature and the cells were 
centrifuged. Finally the cells were fixed in Fixative (3:1 Methanol: Acetic Acid). 
Metaphase spreads were prepared and stained in 10% Giemsa in 1x Sörensens buffer 
for 15min. 
2.2.15 Restriction of genomic DNA 
For the digestion of genomic DNA, 15 µg of genomic DNA was used for each reaction. 
Per µg DNA, 0.3 Fast Digest Unit (FDU) of the enzyme were used. The following 
components were added to the reaction: 
 
DNA    X µL (15 µg) 
FD Restriction Enzyme   4.5 µL (4.5 x 1FDU) 
FD Restriction Enzyme Buffer (10x) 20 µL   
Water       200 µL 
 
For complete digestion, the reaction mixture was incubated without the enzyme for 30 
min at 4°C shaking in a Thermo mixer. After adding the enzyme the reaction was 
incubated for 5 hours at 37°C and shaken every 15 min for 15 min.  
2.2.15.1 Ethanol precipitation of digested genomic DNA  
Ethanol precipitation was carried out by adding 0.1 Vol. of 5M NaCl and 2.5 Vol. of 
100% Ethanol to 200 µL of digested DNA. The mixture was incubated at - 80°C for one 
hour before centrifuging for 30 min at 1300rpm at 4°C. The supernatant was decanted 
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and 200 µL of 70% ethanol was added to the DNA pellet. After repeating the 
centrifugation step the supernatant was removed and the pellet was dried for 10 min at 
37°C. The pellet was dissolved in 25 µL TE. To remove residual Ethanol, the cap of the 
micro centrifuge tubes were opened and incubated at 65°C for 10 min. 
 
2.2.16 Agarose DNA Gel-electrophoresis   
Agarose DNA Gel-electrophoresis was used to separate DNA Sequences according to 
their size. For running Gels with genomic DNA an 0.8% Agarose gel was prepared by 
adding 0.8 g Agarose to 100mL 1 x TAE Buffer and heating in the microwave. After 
complete melting of the Agarose, it was poured into a gel chamber of 10 x 7 cm and was 
left for polymerization. After completely covering the gel with TAE buffer the samples 
were loaded on the gel with 1/10 Vol. of Fermentas Loading Buffer (6 x). The gel was 
run at 0.5Volts/cm for 6 hours. The DNA was stained in 50ml 1 x TAE with 1% Ethidium 
bromide (EtBr) for 30 min while shaking.   
 
2.2.17 Southern Blot 
With the southern Blot Technique, described by Southern in 1975, it is possible to detect 
specific DNA sequences in the genome of cells. In the first step, 15 µg genomic DNA is 
digested with a specific restriction endonuclease and resolved by Agarose gel 
electrophoresis. Subsequently, the DNA is transferred onto a Nylon membrane through 
capillary transfer. After cross-linking the DNA with the membrane, specific sequences of 
the fixed DNA will be hybridized with a radioactive labeled probe.  
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Fig. 13: Schematic illustration of the capillary transfer of Southern blot apparatus. 
The DNA from the Agarose gel is transferred to the Nylon membrane through capillary 
forces. A stream of 20xSSPE solution moves through the gel into the paper towels 
eluting the DNA from the gel and depositing it on the nylon membrane. 
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2.2.17.1 Blotting via capillary transfer  
 
Depurination 
After Gel electrophoresis, the gel was rinsed in distilled water and slowly shaken on a 
platform shaker in Depurination solution for seven minutes. The Depurination treatment 
with 0.2N HCl leads to strand cleavage which allows better transfer of large DNA 
fragments. 
Denaturation 
The gel was rinsed twice in distilled water and treated with denaturation solution twice 
for 15 min. Denaturation solution is required to unzip the DNA and produce single 
stranded DNA for further hybridization. 
Neutralization 
After rinsing twice in distilled water, the gel was shaken two times for 15 min in 
neutralization solution, which elevates the pH above nine to allow binding to the 
membrane. 
Depurination Solution: 0.2NHCl 
 
Denaturation Solution: 1.5M NaCl 
  0.5M NaOH 
 
Neutralization Solution: 1M Tris (pH7.4) 
  1.5 M NaCl 
2.2.17.2 Construction of the transfer apparatus 
The construction of the capillary blot was carried out according to Fig. 13. A container 
was filled with 20xSSPE solution containing a plastic support. A long piece of Whatman 
paper wetted with 20xSSPE was placed on a piece of glass plate which was put over 
the plastic support. The gel was placed upside down on the Whatman paper. A wet 
Nylon membrane was placed on the gel. Between every step, bubbles were rolled out 
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using a glass pipette. Four pieces of plastic wrap were placed on the sides of the nylon 
membrane and stretched over the sides of the plastic container to avoid contact 
between the paper towels and the Whatman paper. Four pieces of Whatman paper 
wetted in 20xSSPE were one by one put over the nylon membrane taken care that 
bubbles between the papers are removed carefully by rolling. A stack of paper towels 
were placed on the top of the Whatman paper to provide capillary action. Finally, a glass 
plate was placed on the top of the paper towels with a 500g weight at the top.  
The transfer was set for 18-20 hours. After the transfer, the membrane was marked with 
a pencil on the opposite side. The membrane was washed briefly in distilled water and 
equilibrated in 6xSSPE. To crosslink the DNA to the membrane, it was baked for 45min 
at 110°C.  
 
20 x SSPE (pH7.4): 3M NaCl  
 0.2M NaH2PO4H2O 
 0.02M EDTA 
 
2.2.17.3 Preparation of the probe 
For the preparation of the probe for hybridization, the pT2SVNeo plasmid was digested 
with HindIII RE following the protocol described above. Various fragments of the 
digested DNA were separated on a 1% Agarose-gel running at 2Volts/cm. The fragment 
of interest (1.7kb) was purified with the Qiagen gel purification kit according to the 
manufacturer’s protocol.  
 
2.2.17.4 Radioactively-labeled DNA probes 
For preparing the radioactive labeled probe, the “Prime-It II Random Prime Labeling Kit” 
from Stratagene was used.  
25ng template DNA with distilled water and 10µL of random oligonucleotide primers 
were prepared in a total volume of 34 µL in a 1.5 mL micro centrifuge tube. After 5 min 
incubation in a boiling water bath, the reaction tube was briefly centrifuged at RT. In the 
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next step, 10µL of dCTP Primer buffer, 5µL of [α-32P] dCTP and 1 µL of Klenow enzyme 
(Exo-) was added to the reaction mixture and incubated at 37°C for 20min. Finally, the 
reaction was stopped by adding 2µL of stop mix.  
Table 1: Reaction Mixture for radioactive probe labeling  
 
Components   Volume 
  25 ng DNA template   x µL 
  Sterile double-distilled H20   x µL 
  5X Random primers solution   10 µL 
  Total Volume   34 µL 
  5X dCTP buffer   10 µL 
  α- 32P dCTP   5 µL 
  Exo (-) Klenow Enzyme   1 µL 
  Stop Mix   2 µL 
 
 
2.2.17.5 Purification of radioactively-labeled probe  
For the removal of unincorporated nucleotides from the DNA labeling reaction, the 
illustraTM ProbeQuant G-50 Micro Columns (GE Healthcare) was used according to the 
manufacturer’s protocol. The activity of the generated probe was then determined by 
Scintillation counting. 
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2.2.17.6 Prehybridization and hybridization of the nylon membrane 
Prehybridization of the nylon membrane 
The nylon membrane was prehybridized for 1h at 65°C in a roller bottle with prewarmed 
Prehybridization solution. Single stranded salmon sperm DNA 10mg/ml was added to 
the solution. To prepare single stranded DNA, 100µL of salmon sperm DNA was heated 
in a 1.5 mL micro centrifuge tube for 5 min in a boiling water bath and was cooled down 
on ice.  
Hybridization of the membrane 
The radioactive labeled probe, 22µL or 2 x 107 cpm was denatured for 5 min at 100°C 
together with 100µL of salmon sperm DNA and chilled on ice for two min before adding 
to the hybridization solution. The membrane was hybridized in a roller bottle overnight.  
Washing the hybridized membrane 
Four washing solutions were prepared ranging from high stringency (1) to low stringency 
(4). After Hybridization, the membrane was washed in solution 1 at RT for 5 min. The 
membrane was kept shaking in solution 2 at RT for 15 min. The Solution 3 was 
prewarmed at 65°C before adding to the beaker containing the membrane and 
incubated for at least 1 hour. The membrane was wrapped in a Saran wrap and 
measured in the interim till the Geiger-Müller counter showed counts of approx. 200Bq. 
In the last step the membrane was washed in Solution 4 for 5 min at RT.  
Washing Solution I:  2 x SSPE 
  0.5% SDS  
 
Washing Solution II:  2 x SSPE 
  0.1% SDS 
 
Washing Solution III: 0.1 x SSPE 
  0.1% SDS 
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Washing Solution IV: 0.1 x SSPE 
 
2.2.18 PCR 
The Polymerase chain reaction was used for the amplification of single DNA sequences 
to obtain DNA fragments for further cloning. The PCR reaction was set up in a total 
Volume of 20µL with concentrations of template DNA ranging from 1ng-10pg. 
Furthermore the reaction contained 100mM dNTP Mix, 1 x PCR-Buffer, 2.5U Taq- or 
PhusionR Polymerase and dist. H20. For primer sequences, refer Appendix, Table 2. 
The amplification reactions were performed in a Thermo-Cycler with the following 
programs:  
Program Cycles Temperature Time 
1 94°C 80 sec Denaturation 
94°C 30 sec. 
Annealing 51-62°C 30-50 sec. 
 
32 
72°C 15sec-60sec. Elongation 
1 72°C 10 min. 
 
 
2.2.19 Cloning 
2.2.19.1 Ligation of PCR Products with the pGEM-T Easy vector 
The PCR products eluted from the Agarose gel with the Qiagen gel extraction kit were 
ligated into the pGEM-T Easy Vector (Promega) in the ratio of 3:1. The Vector contains 
a 3` Deoxythymidine residue at the site of insertion. During PCR amplification, the Taq 
polymerase adds a Deoxyadenosine at the 3` end of the DNA.  
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Ligation reaction mixture: 2.5 µL 2 x rapid ligation Buffer 
    0.5 µL pGEM-T easy Vector 
    0.5 µL T4-DNA-Ligase 
The reaction was made up to 10 µL after addition of the PCR product. The ligation was 
incubated at 22°C overnight.  
2.2.19.2 Ligation of PCR products 
The Ligation of PCR- products were carried out in a total volume of 20 µL. A 1:5 relation 
of Vector insert was used. The reaction mixture contained additionally 0.1 Vol. 10 x 
ligation buffer and 1U T4 Ligase. The reaction mixture was incubated at 22°C overnight.   
2.2.19.3 Heat shock transformation 
For the heat shock transformation, 100 µL competent E.coli cells were transformed with 
10ng of plasmid DNA. The reaction was incubated for 40 min on ice. In the next step, 
heat shock was carried out at 42°C for 45 sec. in the Thermo Mixer and immediately 
incubated on ice for 2 min.  800 µL LB Media was added to the bacterial culture and 
incubated for 1.5 h at 37°C with the speed of rotation set at 220rpm. In the final step, 
200 µL of the culture were plated on LB-Agar plates and incubated at 37°C overnight.  
2.2.19.4 Preparation of competent E.coli cells 
A 100 µL aliquot of frozen cells were inoculated in 200ml LB-Media on a shaker at 37°C 
until they reached an OD600 of 0.4. The culture was chilled on ice for 15min. Also the 
0.1M CaCl2 solution and 0.1M CaCl2 plus 15% glycerol were chilled on ice. The cells 
were centrifuged at 3300g at 4°C for 10 min. The pellet was resuspended in 30 mL cold 
0.1M CaCl2 and incubated on ice for 30 min. After centrifuging the cells again, the pellet 
was dissolved in 6 ml 0.1 M CaCl2 solution plus 15% glycerol. 500 µL aliquots were 
prepared and frozen at -80°C.  
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3 Results 
3.1 Transfection approach versus repair pathway choice 
3.1.1 Repair of DSBs in plasmids transfected by lipofection show only 
marginal defects in D-NHEJ mutants 
IR induced DSBs are randomly generated in the genome, and neither their number nor 
their location are precisely known. Furthermore, in an irradiated cell population, each 
cell sustains DSBs at different locations of the genome, at different numbers, spread 
around a known mean.  
Some of these limitations can be mitigated by analyzing repair of DSBs in plasmid DNA 
in vitro, after transfection into cells of different genetic background. The in vitro 
manipulation of the plasmid DNA allows the generation of DSBs with different but well-
defined ends, usually generated by treatment with appropriate combinations of 
restriction endonucleases. The efficiency of repair is quantitated by end rejoining 
dependent restoration of a reporter gene, e.g. EGFP, and end processing after ligation 
analyzed in bacteria after plasmid rescue. These valuable properties give plasmid 
assays considerable popularity. Yet, the results generated appear highly variable 
suggesting that undefined parameters determine the outcome.  
As a first step toward the characterization of these parameters, we analyzed rejoining of 
DNA ends using the plasmid shown in Figure 14A and described in detail under Material 
and Methods. Digestion of this plasmid with HindIII removes the Ad2 exon and 
generates the compatible DNA ends shown in the inset. Upon successful rejoining in the 
cell, EGFP expression was used to detect and quantitate the event.  
Figure 14B shows the principle of the approach and the signal generated after 
transfection of CHO cells using lipofectamine with a circular version of the plasmid that 
lacks the Ad2 exon (see Materials and Methods). A robust signal is evident that 
indicates a transfection efficiency of nearly 50%.  
An analysis of DSB repair efficiency is summarized in Figure 14D and E. Transfection 
using lipofectamine of the DNA-PKcs deficient mutant XR-C1-3 and their wild type 
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counterpart CHO9 shows efficient plasmid rejoining in both types of cells. The results 
summarized in Figure 14D and the relative inhibition plotted as a function of the amount 
of DNA transfected in Figure 14E show marginal effects at best with a trend for stronger 
effect with increasing amount of transfected DNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14: A. Map of pEGFP-Pem1-Ad2 plasmid used. Digestion with either HindIII 
or I-SceI removes the Ad2 exon and allows, upon successful intracellular plasmid 
circularization, EGFP expression, which is quantified by flow cytometry.  
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B. Flow cytometry histogram depicting EGFP expression from circular (pEGFP-
Pem1) plasmid together with supercoiled DsRed (to monitor transfection 
efficiency) after nucleofection in wild type cells. 
C. Flow cytometry histograms of EGFP and RFP expression 24 hours post 
transfection of HindIII-linearized pEGFP-Pem1-Ad2 plasmid at different DNA 
concentrations together with supercoiled DsRed (to monitor transfection 
efficiency) in XR-C1-3 mutant and wild type CHO9 cells by lipofection. 
D. Determination of Percent Rejoin in DNA-PKcs-deficient XR-C1-3 and wild-type 
CHO9 cells in lipofection by in vivo plasmid assay. Two million cells (for 
nucleofection) and 70-80% confluent cells (60mm dishes for lipofection) were 
transfected with HindIII-linearized pEGFP-Pem1-Ad2 together with supercoiled 
DsRed (to monitor transfection efficiency).  The ratio of GFP+ to Red+ cells was 
calculated (values inserted in the individual dot plots) and used to determine the 
percent rejoining efficiency of cells.  Cells were transfected with various amounts 
of circular and linear pEGFP-Pem1 vector and transfection control pDsRed 
plasmid and the percentages of red and green cells were determined by FACS 
analysis 24 hours post transfection.  The ratio of GFP+ to Red+ cells was plotted 
as a function of the amount of pEGFP-Pem1 vector and used as a measure of 
NHEJ efficiency.  The above experiments were repeated at least 3 times. 
NB: Higher signals are observed in FACS data from lipofection as compared to 
nucleofection although transfection efficiency is less. This is due to the fact that 
nearly double the number of cells were counted in lipofection (all the cells). 
E. A bar plot depicting the relative inhibition of rejoining efficiency at different 
concentrations of HindIII-linearized pEGFP-Pem1-Ad2 plasmid after lipofection. 
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Figure 15 I A summarizes results similar to those described above but for MEFs with 
defect in LIG4. Here again a relatively small inhibition in end joining efficiency is 
observed in LIG4-/-p53-/- cells that reaches significance only at high concentrations of 
transfected DNA. A slightly stronger effect has been observed when examining Ku80 
deficient cells in Figure 15 I C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15 I: A. Determination of percent rejoining in Lig4-/-p53-/- mutant and p53-/- 
wild-type MEF cells after lipofection using an in vivo plasmid assay. Details of the 
experiment as explained above in Fig. 14D. The experiments were repeated at 
least 3 times. 
B. A bar plot depicting the relative inhibition of rejoining efficiency at different 
concentrations of HindIII-linearized pEGFP-Pem1-Ad2 plasmid after lipofection. 
C. Determination of percent rejoining in Ku80-deficient xrs-6 and wild-type CHO9 
cells by in vivo plasmid assay. Details of the experiment as explained above in 
Fig. 14D. The experiments were repeated at least 3 times. 
D. A bar plot depicting the relative inhibition of rejoining efficiency at different 
concentrations of HindIII-linearized pEGFP-Pem1-Ad2 plasmid after lipofection. 
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3.1.2 Repair of DSBs in plasmids transfected by nucleofection show 
dramatic defects in D-NHEJ mutants 
The generally reduced end joining defects measured in D-NHEJ mutants when plasmid 
DNA is used might indicate different processing by the repair apparatus of 
extrachromosomal versus genomic DNA. It is for example possible that B-NHEJ 
operates on extrachromosomal substrates more efficiently than in genomic DNA, 
concealing thus D-NHEJ defects. To examine this possibility we carried out plasmid 
assay experiments using alternative transfection methods. We reasoned that if an 
alternative transfection method generates results similar to lipofection, it will support the 
hypothesis of enhanced function of B-NHEJ on extrachromosomal substrates. If, on the 
other hand, different results were obtained, it would suggest the contribution of as of yet 
uncharacterized parameters. There are reports in the literature pointing to the 
transfection method as a contributing parameter to end joining efficiency when using 
plasmid assays. 
As an alternative transfection method, we chose nucleofection, a special application of 
electroporation that is characterized by very high transfection efficiency. Figure 15 II A 
summarizes the results obtained with DNA-PKcs deficient cells. Notably, when linear 
DNA is introduced into cell using this transfection method, a marked decrease in end 
joining efficiency is observed. When the normalized relative inhibition is plotted for the 
different amounts of DNA transfected a nearly 80% inhibition is observed. For a direct 
comparison with the results obtained after lipofection, the curve measured has been 
transferred from Figure 14E and is included in Figure 15 II B.  
A similar trend is also observed in the results obtained with LIG4-/-p53-/- cells that are 
summarized in Figure 15 II D. The trend is also confirmed in the results with Ku80 
deficient cells summarized in Figure 15 II F, although as expected with these cells the 
difference between lipofection and nucleofection is reduced. 
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Fig. 15 II: A. Determination of percent rejoining in DNA-PKcs-deficient XR-C1-3 
and wild-type CHO9 cells after nucleofection using an in vivo plasmid assay. 
Cells were transfected with various amounts of circular and linear pEGFP-Pem1 
vector and transfection control pDsRed plasmid and the percentages of red and 
green cells were determined by FACS analysis 24 hours post transfection. The 
ratio of GFP+ to Red+ cells was plotted as a function of the amount of pEGFP-
Pem1 vector. The ratio of GFP+ to Red+ was used as a measure of NHEJ 
efficiency. The percent rejoining graphs were generated as mentioned in Fig.  
14D. The above experiments were repeated at least 3 times. 
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B. A bar plot depicting the relative inhibition of rejoining efficiency at different 
concentrations of HindIII-linearized pEGFP-Pem1-Ad2 plasmid in both 
nucleofection and lipofection. 
C. Determination of percent rejoining in Lig4-/-/p53-/- mutant and p53-/- wild-type 
MEFs after nucleofection using an in vivo plasmid assay. Details of the 
experiment as explained above in Fig. 14D. The experiments were repeated at 
least 3 times. 
D. Plot depicting the relative inhibition of rejoining efficiency at different 
concentrations of HindIII-linearized pEGFP-Pem1-Ad2 plasmid in both 
nucleofection and lipofection. 
E.  Determination of Percent Rejoining in Ku80-deficient xrs-6 and wild-type 
CHO9 cells after nucleofection using an in vivo plasmid assay. Details of the 
experiment as explained above in Fig. 14D. The experiments were repeated at 
least 3 times. 
F. Plot depicting the relative inhibition of rejoining efficiency at different 
concentrations of HindIII-linearized pEGFP-Pem1-Ad2 plasmid in both 
nucleofection and lipofection. 
 
Percent rejoining was also calculated from the standard error line and scatter plots with 
2-parameter curve fitting (as earlier) and was found to be 26%, 24% and 18.4% for p53-/- 
cells, 20%, 14% and 9.4% for Lig4-/-p53-/- cells, 46%, 29%, and 15.2% for DNA-PKcs 
mutant XR-C1-3 cells, 22%, 12%, and 4.8% for Ku80 mutant xrs-6 cells and 60%, 41% 
and 25.6% for wild type CHO9 cells. For all above experiments, percent rejoining 
efficiency was also calculated from plots without any curve fitting where all points were 
joined to calculate the percent rejoining at each point denoting the concentration of DNA 
transfected. The rejoining percentages were very similar to the ones obtained above and 
did not significantly differ at any concentration of DNA transfected (data not shown). The 
requirement for CHO9 cells as control for both DNA-PKcs mutant and Ku80 mutant cells 
was further accentuated by the fact that Ku80 complementation in xrs-6/Ku80+ cells was 
not complete and the rejoining efficiency was not very comparable to wild type CHO9 
cells. 
 
3.1.3 Non-specific inhibition of nucleases leaves end-joining characteristics 
unaffected 
When plasmid DNA is transfected in cells and gene expression is allowed the levels of 
signal and their duration will also dependent upon the degradation characteristics of the 
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plasmid by the cellular apparatus. This degradation is thought to involve DNA 
nucleases. It is possible that the different results obtained above after nucleofection and 
Lipofection is due to different kinetics of degradation by the two methods. 
To address this possibility, we inhibited nuclease activity during the initial stages of the 
transfection and measured the outcome of the repair reaction. A widely reported 
nuclease inhibitor ATA (100nM) was used to treat Lig4 and DNA-PKcs mutants and wild 
type cells. The results summarized in Figure 16A and B show that no effect is observed 
in the outcome with nucleofection suggesting that nucleases do not modify the outcome. 
On the other hand, transfection was completely inhibited when the cells treated with 
ATA were used for lipofection and signals were barely detected by flow cytometry. 
 
3.1.4 Difference in the intracellular distribution of transfected DNA between 
lipofection and nucleofection 
An alternative possibility is that the intracellular distribution of plasmid DNA is different 
between the two methods of transfection and causes the observed differences in the 
results. To test this possibility, we carried out plasmid DNA labeling and tracking 
experiments to visualize intracellular plasmid localization after transfection. Two types of 
experiments were designed and carried out with 5µg of CX-Rhodamine-labeled circular 
pEGFP-Pem1 using either lipofection or nucleofection in repair proficient MEFs. Plasmid 
was localized by confocal microscopy 16, 20, and 24 hours after transfection. The total 
DNA-bound CX-Rhodamine signal in the nucleus and the entire cell was determined to 
calculate total cytoplasmic signal by subtracting the former from the latter. A more than 3 
fold higher CX-Rhodamine signal intensities were observed in the nucleus of 
nucleofected cells as compared to lipofected ones. Controls included unlabeled DNA 
transfected with both lipofection and nucleofection, mock transfected cells without DNA 
and untransfected cells.  Whole cell, nuclear and cytoplasmic signal intensities from 
individual cells were plotted as an average of the intensity values (Figure 17A).   
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Fig. 16 A. Effect of the nuclease inhibitor Aurintricarboxylic acid (ATA) on 
DNA double strand break rejoining efficiency of XR-C1-3 mutant and CHO9 
wild-type cells: 100nM ATA was used to treat cells before transfection. 200ng of 
circular and linear pEGFP-Pem1 plasmid was used for nucleofection for all the 
cells with pDsRed2-N1 plasmid used as transfection control. The ratio of 
EGFP+/Red+ was used as a measure of NHEJ efficiency. Percent rejoining was 
calculated as described in Fig. 14D. ATA completely inhibited transfection by 
lipofection. 
B. Effect of nuclease inhibitor ATA on double strand break rejoining 
efficiency of Lig4-/-p53-/- mutant and p53-/- wild-type cells. 100nM of ATA was 
used to treat the cells before transfection. 200ng of circular and linear pEGFP-
Pem1 plasmid was used for nucleofection for all the cells with pDsRed plasmid as 
transfection control. The ratio of GFP+ to Red+ was used as a measure of NHEJ 
efficiency. The percent rejoin graph was generated as mentioned in Fig.  14D. 
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Fig. 17: A. Total CX-Rhodamine signal intensities from whole cell, nuclear 
and cytoplasmic fields: Average intensity from > 50 cells was measured for 
each transfection and nuclear, cytoplasmic, or total signal intensities calculated. 
CLSM color allocation: DAPI-stained nucleus (blue) and CX-Rhodamine-stained 
plasmid DNA (red).  
B. Intracellular DNA Localization experiment: p53-/- MEF cells were 
nucleofected or lipofected with 5µg of CX-Rhodamine-labeled pEGFP-Pem1 
plasmid and fixed 16, 20 and 24 hours later. Cells were stained with DAPI and 
visualized under a Leica TCS SP5 confocal microscope 
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3.2. Models of complex lesions using special arrangements of I-SceI 
recognition sites 
Part II of my thesis deals with the design and development of model systems to study 
the effects of complex DNA lesions based on Sleeping Beauty Transposon technology. 
In this part, we utilize the knowledge gained from experiments of Part I that 
nucleofection is a more effective technique for transfection as compared to Lipofection 
and thus we use nucleofection extensively to establish and authenticate our model 
systems. 
The following results describe how we established the model system which models 
complex types of DSBs as described in the objectives of the project (1.7), and outline 
some of their biological consequences. Finally, the results obtained with the I-SceI 
based system are compared to results obtained by low doses of ionizing radiation. 
 
3.2.1 Synthesis of oligonucleotides bearing I-SceI sites 
Three different oligonucleotides containing I-SceI sites were commercially procured from 
Cloning Biotech (for oligonucleotide sequences, please refer Appendix Table 2). The 
first oligonucleotide (NS) was designed bearing a single I-SceI site, which will serve as a 
control to elucidate the effect of single DSBs on cells. The second (200C) and third 
(200I) oligonucleotides were synthesized consisting of two I-SceI sites separated by 200 
bp. This distance was chosen, since it is known that the length of DNA wrapped around 
a nucleosome is approximately 146 bp, and thus according to our hypothesis, the two 
DSBs induced would be in adjacent nucleosomes, with the possibility that simultaneous 
breaks at both sites may lead to loss of a nucleosome, leading to genomic instability and 
eventually cell death. 200C (C stands for compatible) contains both sites in direct, 
compatible orientation. To increase the degree of DSB complexity, the 200I 
(incompatible) oligonucleotide has the two I-SceI sites in reverse orientation. This 
prevents the direct head-to-head rejoining of the DNA ends, as some sort of processing 
and polymerization will be required before rejoining. These oligonucleotides were 
shipped cloned in the pPCRScript vector at KpnI and SalI sites. 
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Fig. 18: Schematic illustration of I-SceI in compatible and incompatible orientation 
A: I-SceI sites are located in compatible orientation. B: I-SceI sites are located in 
incompatible orientation. The red arrows indicate the site of restriction. The blue bases 
will be cut out after restriction. The black bases will remain as “sticky” ends after 
restriction. 
 
3.2.2 Cloning of the Transposon Donor plasmid 
All three oligonucleotides were cloned into Transposon donor plasmids for multiple, 
random integration into human A549 cells using the SB system.  
The multiple cloning site (MCS) of the Transposon donor plasmid pT2SVNeo along with 
the SV40 Promoter and the Neomycin resistance conferring gene (Fig. 19A) are located 
between the IR/DRs, the Transposase binding sites. The EcoRI site at the MCS was 
selected for non-directional cloning of the oligonucleotides. The oligonucleotides were 
excised from the pPCRScript vector by EcoRI restriction and cloned into pT2SVNeo 
plasmid. The cloning was confirmed by restriction with EcoRI and SacII (Fig. 19B). The 
plasmid containing the oligonucleotide NS was named as pT2SVNeoNS. Post cloning, 
the other two plasmids containing the two sites’ oligonucleotides 200C and 200I were 
named pT2SVNeo200C and pT2SVNeo200I to indicate the compatible and incompatible 
nature of the ends. 
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Fig. 19: pT2SVNeo plasmid with integration of oligonucleotide bearing I-SceI sites 
in incompatible orientation. A. The red arrow indicates the 200bp spacer. The IR/DRs 
are marked with a red circle. The EcoRI site marked in black was used as the cloning 
site. On the right the I-SceI Sequences are represented. The cutting sites are indicated 
by a black arrow. B. 0.8% Agarose-Gel illustrating the test restriction of the clones 
pT2SVNeo200C and pT2SVNeo200I. The lanes 1 and 2 show the 236bp insert fall of 
pT2SVNeo200I. The insert fall of pT2SVNeo200C is illustrated in the lanes 3 and 4. 
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3.2.3 Generation of A549 clones harboring different numbers of I-SceI 
integration sites 
3.2.3.1 Cell line used to establish clones bearing I-SceI sites 
A549 cells were selected (ATCC Number: CCL-185TM human lung carcinoma cells of 
epithelial origin) for our experiments. This cell line has a positive p53 status; it is easy to 
grow and has a relatively stable karyotype. A549 cells are hypotriploid (chromosome 
numbers range from 64-67) and they are devoid of the limited life-span problems 
associated with primary fibroblasts.  
 
3.2.3.2 Testing efficiency of the Sleeping Beauty Transposon system  
Before applying the Transposon technology to integrate the oligonucleotides bearing I-
SceI sites into the genome of A549 cells, we checked the integration efficiency of the 
original Sleeping Beauty Transposon system in A549 cells using transposases of 
different activity kindly provided by Dr. Z. Ivics. The two SB expressing constructs, 
pCMV(CAT)SB100X and pCMV(CAT)SB80X, express transposases with 100 times and 
80 times higher activity than the original transposase. The SB100X yielded the highest 
number of integrations and was therefore chosen for further experiments. On the 
average, 7-8 integrations were achieved with unmodified constructs, as estimated by 
Southern blotting. 
 
3.2.3.3 SB-mediated integration of I-SceI oligonucleotides in A549 cells 
The above described plasmids were co-transfected into A549 cells with the 
transposase-expressing helper construct pCMV(CAT)SB100X at a ratio of 10:1 using 
nucleofection. 
For transfection experiments cells in the exponential phase of growth, as well as 
elutriated G1 cells were used. Transfections with G1 cells were explored arguing that 
better conditions for plasmid integration may be reached in the subsequent S-phase, 
where chromatin is opened for replication. 
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After transfection, cells were plated at different dilutions, ranging from 100 to 5000 
cells/dish for 14 days while selecting for integration using G418. 20 colonies from each 
of the three transfections (60 colonies in total) were picked and tightly selected with 
G418. These 20 clones were passaged, collected and frozen. In total a pool of 5 X 60 
clones (300) of three different kinds of I-SceI clones (clones with one I-SceI site and 2 I-
SceI sites in compatible and incompatible orientation) were generated. In the next step, 
genomic DNA was extracted from a wide number of randomly selected clones from this 
pool and the number of integrations was determined by Southern Blotting. 
 
3.2.3.4 Selection of stable transfectants with G418 
To determine the concentration of G418 required for the selection of NeoR positive 
clones, a kill curve of wild-type A549 cells was prepared using increasing drug 
concentration (G418 solution in 100mM Hepes, pH 7.3). 500µg/mL was determined as 
the required concentration for tight selection.  
 
 
 
 
 
 
 
 
 
Fig. 20: Effect of G418 on A549 cells. A549 cells were treated with different 
concentrations of G418, with (orange line) and without (red line) medium change.   
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The experiment was performed both without and with medium change (fresh G-418 
added every 2 days) so as to determine whether G-418 needs to be replenished to 
maintain its effectiveness. As no significant difference was observed, it was decided to 
proceed without medium change. 
 
3.2.4 Southern blotting to estimate the number of integration sites 
Southern blotting was performed to estimate the number of integration sites in the 
different clones. 
A probe was generated which can be used for single I-SceI site clones as well as for 
clones bearing two sites. For this purpose, the pT2SVNeo plasmid was digested with 
HindIII to digest the sites located between the two IR/DRs downstream of the EcoRI site, 
which was used to clone the I-SceI constructs. The sequence has a size of 1.72kb, 
contains the NeoR gene and a CMV promoter (Figure 21), which is complementary to a 
part of the integrated cassettes in the different clones. The eluted sequence was labeled 
with α-32P radioisotope (α-32P dCTP) utilizing standard protocols (2.11.4). 
 
 
 
 
 
 
 
 
Fig. 21: Illustration of the DNA fragment between the IR/DRs of the pT2SVNeo 
plasmid utilized to generate the probe. Two HindIII restriction sites are located in the 
sequence. The first is located at position 627 (starting from Position 1 as the first bp in 
the IR/DR) and the second at position 2359.  
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In total, 24 clones bearing two I-SceI sites and seven clones bearing a single I-SceI site 
were checked for the number of integrations. The results obtained are shown below. In 
Fig. 22A and B, Southern blotting results are shown for clones with two I-SceI sites in 
compatible (Fig. 22A lanes 1-4, Fig. 22B, lanes 4-7) and incompatible orientations (Fig. 
22A lanes 5-9, Fig 22B lanes 1-3). The number of integrations ranges from 3 to 12. Fig. 
22C shows the results of clones generated from transfected G1 cells (lanes 1-4 
incompatible, lanes 5-8 compatible). Compared to the results obtained from 
exponentially growing cells, the number of integrations in G1 cells is not significantly 
increased. The clone in lane 3 shows the highest number of integrations. Southern Blot 
with clones bearing a single I-SceI site (Fig. 22D) shows integrations ranging from 3 to 
7.  
All clones were named according to the number of integration sites. The following clones 
from sets of C (compatible) and I (incompatible) were selected for further experiments: 
200SA549C4(8), 200SA549C9(18), 200SA549C11(22), 200SA549I8(16), 
200SA549I3(6). 200SA549I6(12) 200SA549I12(24). In brackets, the number of I-SceI 
sites are indicated, which is double in clones bearing integrations with two I-SceI sites 
and the same in clones bearing a single I-SceI site. 200S stands for the 200bp spacer 
and A549 for the parent wild type cell line without integrations. 
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Fig. 22: A. Southern blot of neoR resistant clones from different 
transfection. Southern blots show the number of integration sites estimated from 
the generated signal. A. Clones with integrations of two I-SceI sites and control 
cells. B. As in A for different clones. C. Clones from transfected G1 cells with two 
I-SceI sites. D. Clones with integrations bearing a single I-SceI site. NB: C: A549 
control, A200C: clones with compatible I-SceI sites and 200bp spacer, A200I 
clones with incompatible I-SceI sites. 1SB: clones with a single I-SceI site. Clones 
used in Experiments are marked in red.  
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3.2.5 Clonogenic cell survival assay 
The clonogenic assay or colony formation assay[138], measures the ability of a single 
cell to grow into a colony and is extensively used to measure the effect of cytotoxic 
agents. By convention, a colony must consist of at least 50 cells. A cell survival curve is 
therefore the relationship between the dose of the agent used to introduce damage and 
the fraction of cells retaining their ability to form colonies. Clonogenic cell survival 
assays were initially described for studying the effects of IR, but are now widely used to 
examine the effects of other agents like chemotherapeutic drugs and cytokines. In our 
case, we introduced this assay to estimate the effect of DSBs generated by the I-SceI 
homing endonuclease at the sites of integration in the above described clones. 
 
3.2.5.1 Radiosensitivity of clones with transposon integrations 
As mentioned in the last section, a range of clones were selected for further experiments 
depending upon the number of integrations of single or double I-SceI sites. Since the SB 
Transposase-mediated integrations are random, mutagenic events that affect cell 
radiosensitivity to killing cannot be ruled out. Therefore, we tested the radiosensitivity to 
killing of the following clones, two with compatible I-SceI ends (9 and 11 integrations), 
and one with incompatible I-SceI ends (12 integrations) along with untransfected A549 
cells. 
Cells were irradiated with 4, 8 and 12Gy of X-rays, trypsinized immediately and plated in 
a way aiming to the same number of colonies per dish, irrespective of the dose of 
radiation delivered. Colonies were allowed to form for 14 days, then stained and 
counted.  
Figure 23 shows the survival curves obtained. As it can be deduced from the graph, 
equivalent cell killing was observed at all delivered doses for all cell lines tested 
irrespectively of whether they had been transfected with I-SceI containing constructs. 
Results 
 77
 
 
 
 
 
 
 
 
 
 
Fig. 23 Survival curves of wild type A549 cells and clones bearing I-SceI sites in 
compatible and incompatible orientations. Cells were plated in duplicates and allowed 
to form colonies for 14 days. 
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3.2.5.2 I-SceI expression constructs 
The aim was now to perform colony formation assays with clones bearing defined 
number of integrated I-SceI sites along with the parent A549 control, based exactly on 
the principle of colony formation assays performed with IR. For the following 
experiments, we utilized two different types of expression constructs of I-SceI. The first 
one, named pCMV-I-SceI-3xNLS, expresses I-SceI constitutively with three nuclear 
localization signals to facilitate transfer of expressed I-SceI to the nucleus.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 24: Live cell imaging pictures depicting transport of EGFP-tagged I-SceI from 
cytoplasm into the nucleus. The above Figure utilizes live cell imaging to show the 
transport of EFGP-I-SceI-GR chimera from the cytoplasm to the nucleus upon addition of 
the ligand TA. The upper panel shows cells with the chimera in the cytoplasm 24 hours 
post transfection with pEGFP-I-SceI-GR plasmid. Note the GFP signal primarily seen 
only in the cytoplasm in the absence of TA, with the nucleus mostly clear. The lower 
panel shows cells treated with the ligand TA. The images were acquired 5 min after 
addition of TA. Note the transport of the GFP signal to the nucleus which is now seen in 
bright green color.  
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The second is an inducible construct named pEGFP-I-SceI-GR, which expresses a 
chimeric protein of EGFP, I-SceI and a Glucocorticoid Receptor Ligand binding domain, 
which remains cytoplasmic until supplied with triamcinolone acetonide (TA). On addition 
of TA, the expressed chimera is immediately transported into the nucleus leading to 
excision at the recognition sites of I-SceI, which in our case are integrated into the 
genome of A549 cells.  
This system theoretically mimics the effects of IR, as all the DSBs should be triggered 
simultaneously. 
Figure 24 shows live cell imaging pictures depicting the expression of GFP tagged 
chimeric I-SceI in the upper panel, which gets transported into the nucleus within 5 min 
of addition of TA, as seen in the lower panel. Despite the impressive 
compartmentalization indicated here using imaging technologies, functional assays 
described below indicate that the system may be leaky (see 2.3.3). 
 
3.2.5.3 Cells survival after transfection with I-SceI 
We measured cell survival in clones bearing single I-SceI and double I-SceI sites at 
different numbers. This assay has never been utilized before for determining the effect 
of homing endonuclease-induced DSBs on cell survival.  
We devised two different protocols (see Figure 10) for these experiments in which the I-
SceI expressing construct was transfected using Nucleofection. In the first step, 2 million 
cells of each clone were transfected with 2µg of I-SceI expression plasmid. According to 
the first protocol, the cells were plated in duplicates of 100 and 200 cells immediately 
after transfection. After 24h hours, TA was added to the cells and was removed after 8-
10 hours of addition.  
The second protocol was designed to exclude cells killed by the transfection. Therefore, 
cells were returned to culture for 24h at high numbers after transfection and were 
subsequently treated with TA 10-12 hours under the same conditions. Only at this point, 
cells were trypsinized and plated in duplicates of 100 and 200 cells. We observed similar 
results with both protocols.  
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3.2.5.4 Determination of transfection efficiency 
All experiments included controls for determining the transfection efficiency. 
Transfection experiments have the inherent weakness that transfection efficiency is 
rarely 100%. Ideally, in our experiments, all transfected cells should receive the I-SceI 
expression construct to ensure that DSBs are induced in all cells. Since this is not 
possible in practice it generates a complication that must be considered in the 
interpretation of the results obtained. For determining the transfection efficiency in our 
experiments, a construct supplied with the Lonza Nucleofector® kit (pMaxGFP) 
expressing EGFP was transfected in parallel and the percentage of green cells was 
determined by FACS, 24 hours post transfection. Transfection efficiency typically varied 
between 75 – 90%. 
 
3.2.5.5 Survival of clones bearing single I-SceI site integrations 
Survival assays were performed with clones bearing 3, 6 and 7 integrations of single I-
SceI sites NSA5493(3), NSA5496(6) and NSA5497(7). NS stands for no spacer.  
The survival is plotted as of function of the number of integrated I-SceI sites. As it is 
shown no substantial killing was observed with any of the clones (Figure 25). The 
survival curve is a straight line starting from origin and running parallel to the dose axis. 
Comparable results were obtained with constitutive and inducible I-SceI expression 
constructs, and the effect of the latter was independent of the presence of the inducing 
agent. No clear increase in cell killing was witnessed with increasing number of I-SceI 
integration sites.  
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Fig. 25: .Survival Curves of clones bearing single I-SceI sites with 3, 6 and 7 
integrations (NSA5493(3), NSA5496(6) and NSA5497(7)). A: Clones were transfected 
with pCMV-I-SceI-3xNLS .B: Clones were transfected with pEGFP-I-SceI-GR 
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3.2.5.6 Clonogenic Survival assay with clones bearing pairs of I-SceI sites 
As colony formation with clones bearing single I-SceI sites in multiple numbers showed 
no killing, we proceeded to test clones bearing pairs of I-SceI sites separated by a 
distance of 200 bp. Similarly to clones with single I-SceI sites, initially 4 clones were 
selected on the basis of number of integrations determined by Southern Blotting. Two of 
these clones were with the two I-SceI sites in compatible orientations (200SA549C9(18) 
and 200SA549C11(22)) and two with sites in incompatible orientations (200A549I8(16) 
and 200A549I12(24)). In Fig. 26A the results are shown obtained from transfection 
experiments of the different clones with the pCMV-I-SceI-3xNLS construct.  
In the graph representing cells harboring the pairs of I-SceI sites in incompatible 
orientation 200SA549I8(16) and 200SA549I12(24), the results point to an initial strong 
killing effect. The dose-response curve is a straight line starting from origin and showing 
approx. 80% killing for the clone bearing 16 I-SceI sites (200SA549I8(16)). It reaches a 
plateau at this point and it is not further increased in the clone bearing 24 I-SceI sites 
(200SA549I12(24)). Clones with pairs of I-SceI sites in compatible orientations show a 
consistent increase in cell killing with increasing number of integration sites. The clone 
bearing 18 I-SceI sites (200SA549C9(18)) shows no initial killing, but the 
200SA549C11(22) clone with 22 sites shows killing greater than 50%.  
To investigate the initial points of the survival curves, we performed experiments with 
clones bearing lower numbers of integrations. Figure 26B shows the results obtained. 
As can be deduced from the plot, the clones bearing the I-SceI sites in incompatible 
orientations still show substantial killing with the clone bearing 6 I-SceI sites 
(200SA549I3(6)) showing approx. 70% lethality, and the clone bearing 12 sites 
(200SA549I6(12)) leading to a cell lethality of nearly 90%. The clone with 24 sites 
((200SA549I12(24) again shows a killing of 90%, which is in agreement with the results 
obtained earlier.  
On the other hand, clones bearing two I-SceI sites in compatible orientation show less 
killing. Here, the clone with 4 sites (200SA549C2(4)) showed approx. 30% killing and 
the clone with 18 I-SceI sites (200SA549C9(18)) 70%.   
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Fig. 26 Survival curves of clones bearing pairs of I-SceI sites. A. The different clones were 
transfected with pCMV-I-SceI-3xNLS. The survival experiment was carried out with two clones 
with sites in compatible orientations and 9 or 11 integrations (200SA549C9(18), 
200SA549C11(22), black curve) and two clones with sites in incompatible orientations, with 8 
and 12 integrations (200SA549I8(16) and 200SA549I12(24) red curve). B The clones were 
transfected with the pEGFP-I-SceI-GR Plasmid. Two clones with compatible sites bearing 4 
(200SA549C4(8)) and 9 (200SA549C9(18)) integrations and three clones with incompatible sites 
bearing 3,6 and 12 integrations (200SA549I3(6), 200SA549I6(12) and 200SA549I12(24)) were 
used in this experiment.  
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3.2.6 Results of G2-PCC - Determination of chromosomal aberrations 
The cell survival data clearly implies that DSB pairs show an increased killing potential 
compared to single DSBs. In the following steps, we inquire how this strong killing is 
mediated.  
For this purpose and in order to validate the results obtained with survival assays, we 
attempted to visualize the transformation of the enzyme-induced DSBs to chromatin 
breaks. We analyzed metaphases in I-SceI plasmid transfected cells treated with 
Colcemid, but chromosome breaks or other forms of chromosome aberrations were only 
rarely observed. To increase the sensitivity of the assay we performed G2 Premature 
Chromosome Condensation (G2-PCC) to visualize I-SceI-induced chromosome breaks 
before repair.   
Two sets of experiments were designed to examine chromatid breaks induced by I-SceI. 
In the first set of experiments, cells were additionally treated with β-AraA and in the 
second cells were treated with hypertonic solution (500mM NaCl). The repair inhibitor β-
9-D-arabinofuranosyladenine (β-AraA) is a nucleoside analog known to inhibit DNA 
polymerases alpha and beta, thus inhibiting DNA synthesis [136, 139]. Hypertonic 
solution is thought to act by condensing chromatin, thus potentiating the effect of 
radiation or of DSBs [140, 141] 
 
3.2.6.1 Calyculin-induced G2-PCC 
Chromosome damage was analyzed in G2 after induction of premature chromosome 
condensation using Calyculin A. G2-PCC can be induced by the Serine/Threonine 
Phosphatase inhibitor Calyculin A [142]. It dephosphorylates the Serine/Threonine 
Phosphatases PP1 and PP2A which regulate the activity of the cell cycle checkpoint 
protein Cdc25. Cdc25 is a Tyrosine Phosphatase that activates the maturation mitosis 
promoting factor (MPF), a complex of p34cdc2/cyclinB. MPF promotes chromosome 
condensation and is active in its dephosphorylated form. MPF is normally active only in 
the M phase of the cell cycle corresponding to the high Cyclin B1 concentration at this 
cell cycle phase. Calyculin A indirectly activates the MPF factor by dephosphorylating 
PP1 and PP2A and forcing interphase cells into premature mitosis that is associated 
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with premature chromosome condensation (PCC). Due to the oscillation of Cyclin B1 
through the cell cycle, PCC is predominantly induced in G2 phase followed by S Phase. 
 
3.2.6.2 G2-PCC in cells transfected with pEGFP-I-SceI-GR 
The induction of DNA damage at the chromosome level was measured by G2-PCC 
[143]. All experiments were performed with exponentially growing cells. In the first step, 
four million of A549 human cells and four million of each of four different clones with 
different number of I-SceI integration sites (200SA549C9(18), 200SA549C11(22), 
200SA549I8(16) and 200SA549I12(24)) were transfected with the I-SceI expressing 
plasmid pEGFP-I-SceI-GR (1µg/Mio cells). The transfected wt A549 cells, as well as the 
four different clones were plated in 90-mm dishes, one million cells/dish in 15 ml 
McCoy’s medium supplemented with 10% FCS. As a control, one million cells/dish of 
untransfected cells from each cell line were plated at the same time. In the following 
steps, the controls were treated the same way as the transfected cells. 24h post 
transfection, TA was added to the cells to initiate the transport of I-SceI into the cell 
nucleus. Cells were harvested at 4h post addition of TA. Calyculin A was added 30 min 
before fixation at a final concentration of 100nM. Colcemid was also added four hours 
prior to fixation to enable a metaphase block and prevent the loss into G1 (where 
chromosome analysis is not possible) of cells that could otherwise be analyzed. 
 
3.2.6.3 G2-PCC of 0.5 Gy X-ray treated cells 
Simultaneously, a set of irradiated cells were prepared to compare the number of DSBs 
induced by 0.5Gy X-rays to the number of breaks induced by restriction of I-SceI sites. 
0.5 Mio. cells/dish of A549, 200SA549C9(18), 200SA549C11(22), 200SA549I8(16) and 
200SA549I12(24) were radiated with 0.5Gy X-rays which corresponds to the induction of 
15-20 DSBs, similar to the putative number of DSBs induced by restriction of I-SceI sites 
in the selected clones. The cells were harvested 4h after irradiation and after treatment 
with Calyculin A for 30 min and with Colcemid block for four hours. In the last step, the 
cells were fixed for analysis. 
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3.2.6.4 Effect of β-AraA treatment on pEGFP-I-SceI-GR transfected and 
irradiated cells 
Treatment with β-AraA significantly enhanced the incidence of G2-PCC breaks in clones 
after induction of DSBs as compared to wild type A549 cells, suggesting the activation of 
DNA repair systems upon induction of DSBs by I-SceI. A two to three fold higher 
incidence was observed in cells harboring two closely spaced DSBs than in wild type 
A549 cells (Fig. 27). Compared to the wild type A549 cells, which have in general one 
chromatid break per cell, all clones show a significant increase in G2 PCC breaks/cell, 
which is two to four fold higher. The 200SA549C9(18) clone with 9 integrations of I-SceI 
sites in compatible orientation show two chromatid breaks/cell, whereas the clone 
200SA549I8(16) with 8 integrations of I-SceI sites in incompatible orientations showed 
approx. 4 chromatid breaks per cell. The other two clones 200SA549C11(22) and 
200SA549I12(24) with higher number of integrations and with sites in compatible and 
incompatible orientations respectively did not show much variation and also had approx. 
4 chromatid breaks per cell. The black bars represent transfected cells, which were not 
treated with β-AraA. A549 and all untreated clones bear approx. 0.1 chromatid breaks. 
The low number of breaks in cells not treated with -araA further points out the lack of 
correlation between cell killing and chromosome aberration formation in all these clones. 
The results with -araA will require additional analysis and controls to exclude artifacts. 
In the cells irradiated with 0.5Gy X-rays, the number of G2 PCC breaks ranged for all 
clones from 3.8 to 5.2 breaks per cell. The black bars representing the irradiated 
controls without treatment show a similar number of breaks among all clones, which are 
approx. 0.4 G2PCC breaks per cell. 
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Fig. 27: G2-PCC fragments in clones harboring the indicated number of 
integrations of pairs of I-SceI sites separated by 200bp after treatment with β-AraA. 
A. Bar graph with respective representative micrographs of clones transfected with TA-
inducible pEGFP-I-SceI-GR construct to generate DSBs, as well as untransfected 
controls. The red bars represent the number of G2-PCC breaks/cell in β-AraA treated 
cells. B. Radiation Control (0.5 Gy X-rays). Red bars represent irradiated cells treated 
with β-Ara A. C Picture of Chromosomes transfected and treated with β-AraA. D. Picture 
of Chromosomes irradiated and treated with β-AraA. N.B.: C9(18) and C11(22) represent 
200SA549C9(18) and 200SA549C11(22)clones respectively with pairs of I-SceI sites in 
compatible orientations with 9 or 11 integrations, resulting in 18 and 22 DSBs 
respectively. I8(16) and I12(24) represent 200SA549I8(16) and 200SA549I12(24) clones 
respectively, with the pairs of I-SceI sites in incompatible orientations. Red arrows 
indicate the G2-PCC breaks. 
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3.2.6.5 G2-PCC of cells after hypertonic solution treatment 
In the second set of experiments with the identical objective of preventing the repair of I-
SceI-induced DSBs, the cells were treated with hypertonic solution (500mM NaCl in 
PBS) 3h prior to fixation for a duration of 20min. Hypertonic treatment of cells is 
performed to induce condensation of chromatin [140]. It is hypothesized that repair 
proteins have difficulty to access DSBs in condensed chromatin; therefore repair of 
DSBs is thought to be inhibited in hypertonic solution treated cells. Furthermore, 
chromatin destabilization may allow the transformation of DSBs into chromosome 
breaks, which would have missed detection otherwise. 
3.2.6.6 Effect of hypertonic treatment on pEGFP-I-SceI-GR transfected and 
irradiated cells 
Compared to A549 which has 0.1 G2-PCC breaks/cell, all clones show significant 
increase in breaks, up to seven fold. The number of G2-PCC breaks ranges from 0.4 in 
200SA549C11(22)and 200SA549I8(16), to 0.5 in 200SA549I12(24) and 0.7 breaks/cell 
in 200SA549C9(18). The black bars represent untransfected cells treated with 
hypertonic solution. The untransfected clones show breaks ranging from 0.1 to 0.4 G2-
PCC breaks per cell (Figure 28A). Irradiated cells of all clones have approx. 0.3 - 0.6 
G2-PCC breaks per cell (black bars, Figure 28B). The G2-PCC breaks of irradiated cells 
(0.5 Gy) with hypertonic treatment vary between the different clones from approx. 1.8 in 
A549 to 0.4 in 200SA549C11(22). 
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Fig. 28 G2-PCC fragments in clones harboring the indicated number of 
integrations of pairs of I-SceI sites separated by 200bp after Hypertonic treatment 
(500mM NaCl) A. Bar graph with representative micrographs of clones transfected with 
TA-inducible pEGFP-I-SceI-GR construct, together with untransfected controls. B. 
Radiation control (0.5 Gy X-rays). Red bars represent irradiated cells treated with 
hypertonic solution. C Picture of chromosomes transfected and treated with hypertonic 
solution. D. Picture of chromosomes irradiated and treated with hypertonic solution. 
N.B.: C9(18) and C11(22) represent 200SA549C9(18) and 200SA549C11(22) clones 
respectively, with two I-SceI sites in compatible orientations with 9 and 11 integrations, 
resulting in 18 and 22 DSBs, respectively. I8(16) and I12(24) represent 200SA549I8(16) 
and 200SA549I12(24) clones, respectively, with the pairs of I-SceI sites in incompatible 
orientation. Red arrows indicate the G2-PCC breaks. 
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3.2.7 Determination of the fate of I-SceI sites after restriction analyzed 
by PCR 
3.2.7.1 Genetic consequences of simultaneous restriction of two closely 
spaced I-SceI sites 
Previous results demonstrated that the induction of DSBs by I-SceI has deleterious 
consequences for the cell in terms of survival. Now, the question arises as to how the 
repair mechanisms deal with such DSBs. For this purpose, we used PCR to analyze the 
DNA sequence at the repair junction between two I-SceI sites. Primers were designed 
which flanked the two I-SceI sites 57bp upstream and 138bp downstream. As template 
DNA from the clone 200SA549I8(16) was used, bearing 8 integration sites in 
incompatible orientations. Theoretically, in untreated cells all eight sites should give rise 
to the same product. After digestion and successful rejoining, the PCR products could 
be of different sizes depending on how repair modified the junction. To enable the 
sequencing of this mixture of PCR products, the DNA fragments were cloned into the 
pGEM-T Easy vector system (Figure 29). After transformation in E.coli cells, every 
plasmid should bear a single PCR product of one integration site. In the next step, PCR 
was performed in 10 randomly picked clones and two clones were sequenced. 
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Fig. 29: Schematic illustration of the PCR analysis of the sequence containing the 
two I-SceI sites. After the sequences were amplified by PCR, products were run in 
agarose gels and the different bands were eluted and cloned into the pGEM-T Easy 
vector. 10 colonies were picked for colony PCR and run on 1% Agarose gel. Colonies 
containing 149 bp sequence and 450 bp sequence were subsequently sequenced. The 
blue arrows indicate the forward and reverse primers. 1. PCR, left band - A549, right 
bands – 200SA549I8(16), 4. Colony PCR, left band - A549, right band - 200SA549I8(16). 
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3.2.7.2 Deletion of intervening sequence between the two I-SceI sites 
Two different DNA sequences were obtained after sequencing the different E.coli clones 
obtained from the pEGFP-I-SceI-GR transfected 200SA549I8(16) cells. One clone 
showed the original sequence where no genetic changes could be detected. The other 
sequence showed a 294bp deletion, see Fig. 30. In this sequence, both the I-SceI sites 
had been deleted by the repair machinery and additionally 45 bp had been deleted 
upstream of the first I-SceI restriction site and 23bp downstream of the second site. This 
suggests that two simultaneously induced DSBs are repaired as a single DSB by error 
prone NHEJ repair machinery using extensive trimming of ends. Also, it must be noted 
that there was a loss of the intervening fragment between the two I-SceI sites 
suggesting destabilization of chromatin. 
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Fig. 30: Schematic illustration of the sequence deletion due to error prone repair of 
I-SceI-induced DSBs. A: Schematic illustration of the sequence harboring two I-SceI 
sites. The blue arrows indicate the primer binding sites. B: The white area in the PCR 
product sequence indicates the site of deletion which spans 294bp. C: The sequences 
are illustrated in Bioedit program format. In the top panel, the deletion is shown, ranging 
from position 130bp to 430bp (starting at base pair 1 from the forward primer binding 
site). The lower panel of the Bioedit figure shows the original sequence integrated in the 
genome before incision with I-SceI. The red boxes indicate the two I-SceI sites in the 
uncut sequence. D: Original Sequence in FASTA format.  
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3.2.8 Immunofluorescence: Determination of γ-H2AX foci induction in 
response to I-SceI-induced DSBs 
In higher eukaryotes, DSBs promptly induce the phosphorylation of the histone H2A 
variant, H2AX, at Serine 139 to generate γ-H2AX[34]. Regions with γ-H2AX are 
conveniently detected in chromatin by Immunofluorescence Microscopy. It has been 
shown that there is an approx. one-to-one relationship of γ-H2AX foci with number of 
DSBs induced and this has quickly become a standard for microscopic determination of 
DSB induction and repair kinetics.  
We determined γ-H2AX foci induction upon I-SceI-induced DSBs by utilizing confocal 
microscopy. In these experiments, exponential phase cells at a concentration of 2 x 106 
were nucleofected with 4µg of pEGFP-I-SceI-GR plasmid and plated in 35 mm dishes 
containing poly L-Lysine-coated coverslips. 24 hours post transfection, the cells were 
treated with the drug TA and cells were fixed with 2% Paraformaldehyde after 90 min for 
γ-H2AX foci analysis. DAPI was used as a nuclear stain. Controls were included in the 
experiments where TA was not added along with blank and only transfection reagent 
treated cells. Due to the high cell toxicity of nucleofection, the experiment was then 
performed with LipofectamineTM 2000 reagent and a transfection efficiency of 35-40% 
(determined by EGFP-FACS) with lesser cell toxicity was observed. In experiments with 
LipofectamineTM, cells were first plated in 35 mm dishes containing poly L-lysine-coated 
coverslips at a concentration of 0.2 x 106. The cells were transfected the following day 
with 4µg of pEGFP-I-SceI-GR plasmid including all appropriate controls.  
Since, we could not distinguish between background and induced γ-H2AX foci, we 
determined total number of γ-H2AX foci per cell for several fields and plotted the focus 
distribution pattern for transfected and untransfected clones. As seen in Figure 32, in 
A549 cells, the distribution of foci remains more or less constant in untransfected and 
transfected cells. In cells bearing 9 pairs of I-SceI sites in compatible orientations, a 
general increase in number of cells with γ-H2AX foci ranging from 1 to 17 was observed 
after transfection as compared to the untransfected cells. 
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Similarly, in a clone bearing 8 pairs of I-SceI sites in incompatible orientations, a general 
increase in number of cells with γ-H2AX foci ranging from 1 to 16 was observed after 
transfection as compared to untransfected cells. Thus despite the pronounced killing 
observed in this clone, γ-H2AX foci formation could not be conclusively established. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 31: Representative images of cells with γ-H2AX foci. A. 1Gy X-rays 
irradiated sample. B. Wild type A549 control after transfection with I-SceI 
expression construct. C. 200SA549I8(16) clone after transfection with I-SceI 
expression construct. 
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Fig. 32: Determination of γ-H2AX foci upon induction of DSBs by I-SceI. A. Plot 
representing distribution of γ-H2AX foci across wild type A549 cells. B. Plot representing 
the distribution of γ-H2AX foci across cells of a clone bearing 9 pairs of I-SceI sites in 
compatible orientation. C. Plot representing the distribution of γ-H2AX foci in cells of a 
clone bearing 8 pairs of I-SceI sites in incompatible orientation. Black bars represent 
untransfected cells bearing γ-H2AX foci. Red bars represent cells with γ-H2AX foci, 
which were transfected with I-SceI expression construct. Note the different scales. 
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3.2.9 DNA damage leads to activation of the G2 checkpoint 
As the name suggests, checkpoints in the cell cycle facilitate repair of damaged 
chromatin before a cell transits into the next phase of the cell cycle. Of the three known 
and well characterized G1[144], S[145] and G2 checkpoints[146], the G2 checkpoint is 
the most potent. It is located at a sensitive juncture of the cell cycle phase before the cell 
enters mitosis. IR is known to induce a strong G2 checkpoint, lasting several hours 
depending upon the dose delivered. Thus, activation of G2 checkpoint after DNA 
damage leads to altered distribution of cells throughout the cell cycle, which can be 
determined either by measuring the DNA content of the cells by PI staining at various 
time points after induction of the damage, or by determining the Mitotic index at these 
time points after damage induction, since arrest in G2 will quickly reduce the number of 
cells reaching mitosis. 
3.2.9.1 Determination of G2-Checkpoint on induction of DSBs by I-SceI 
IR is known to induce a strong G2 arrest, which can be easily visualized by the 
accumulation of cells in G2. We tried to determine if the DSBs induced by I-SceI have 
the same effect. In the following experiment, we utilized a clone with compatible I-SceI 
sites 200SA549C9(18) and one with incompatible ends 200SA549I8(16) along with 
A549 controls. All three cell lines were transfected with pEGFP-I-SceI-GR and the 
expressed I-SceI was induced with TA 24 hours post transfection. Cells were collected 
at various time points post transfection and fixed with 70% ethanol for PI staining 
(described in materials and methods). Figure 33 shows plots with the percentage of G2 
cells as a function of time post TA. As can be deduced from the plots, a clear increase in 
G2 population is witnessed after approximately 24 hours post transfection with both the 
clones, whereas no increase in G2 population is witnessed in wild type A549 cells. This 
24 hour time point exactly corresponds to the time of addition of TA to the cells, and 
presumably is a result of the induction of DSBs by I-SceI. However, the similar size 
fluctuations observed in the controls preclude a conclusive interpretation. 
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Fig 33. Determination of G2 checkpoint activation upon induction of DSBs by I-
SceI. A, B. Plots representing two independent experiments depicting the G2 population 
of clones bearing 9 and 8 pairs of I-SceI sites in compatible and incompatible orientations 
along with wild type A549 controls after transfection with pEGFP-I-SceI-GR construct 
with samples collected at various time points up to 33 hours post transfection. C. Plot 
representing the G2 population of untransfected clones bearing 9 and 8 pairs of I-SceI 
sites in compatible and incompatible orientations respectively along with wild type A549 
control with samples collected at various time points until 30 hours post transfection. 
Black splines represent wild type A549 cells. Red splines represent a clone with 9 pairs 
of I-SceI sites in compatible orientations. Green splines represent a clone with 8 pairs of 
I-SceI sites in incompatible orientations. 
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It must be mentioned though that there was no significant difference observed in the G2 
population of clones with compatible or incompatible I-SceI ends at the 25 hour time 
point. It is also important to note that since the G2 population in both clones started to 
increase 20 hour post transfection, this could potentially be due to the leakiness of 
expressed I-SceI into the nucleus (as discussed earlier).  
3.2.9.2 Determination of G2-Checkpoint activation upon induction of DSBs 
by I-SceI homing endonuclease by measurement of Mitotic Index 
In the next step, we studied the activation of G2-checkpoint by determining mitotic index 
through flow cytometry. Mitotic index (MI) variations also reflect the G2 checkpoint 
activation and provide a higher sensitivity of detection than G2 phase accumulation. 
Histone H3 is phosphorylated at Serine-10 (Histone H3 pS10) early in mitosis and 
therefore an antibody against phospho-histone H3 can be used to assess the IR-
induced G2 checkpoint delay or entry into mitosis [147]. Histone-H3 pS10 staining is 
very specific for mitotic cells. 
The experiment was performed with a clone bearing 8 pairs of I-SceI sites in 
incompatible orientation (200SA549I8(16)) and A549 cells as a control. 24 hours post 
transfection with pEGFP-I-SceI-GR, cells were collected at 0, 1 and 3h time points post 
addition of the drug TA and were processed for H3 pS10 stain. They were also 
simultaneously stained for DNA content with PI (multivariate FACS) (detailed description 
in Materials and Methods). Figure 34A depicts the results obtained. A decrease in 
Mitotic index was observed at all time points with the clone 200SA549I8(16), suggesting 
that the I-SceI inducible system was leaky and lead to the reduction of MI even without 
the addition of TA. 
Figure 34A shows a plot of mitotic index determination of a clone 200SA549I8(16) at 0, 
1 and 3 hours either post irradiation with 0.5 Gy X-rays or after addition of TA 24 hours 
post transfection with pEGFP-I-SceI-GR or untransfected both in the presence or 
absence of caffeine. Caffeine is known to abrogate G2 checkpoint. In this plot, caffeine 
completely abrogates the G2 checkpoint as seen by the maintenance of mitotic 
population moving through the cell cycle at all the observed time points with both 
irradiated and transfected cells, whereas MI drops to near zero for irradiated population. 
A drop is observed in MI as compared to untreated cells at all three time points of 0, 1 
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and 3 hr post addition of TA in caffeine untreated cells. In caffeine treated transfected 
cells, MI is observed to increase marginally. 
Figure 34B shows a plot of mitotic index determination of A549 cells at 0, 1 and 3 hours 
either post irradiation with 0.5Gy X-rays or after addition of TA 24 hours post 
transfection with pEGFP-I-SceI-GR and untransfected cells both in the presence or 
absence of caffeine. Although in the transfected cells, a drop in MI is witnessed as 
compared to the untreated cells, no difference in MI was observed in transfected cells 
whether in presence or absence of caffeine. Similar to results obtained with the clone 
200SA549I8(16), Caffeine completely abrogated the G2 checkpoint leading to the 
restoration of normal MI in irradiated cells, whereas in absence of Caffeine MI drops to 
near zero for irradiated population. 
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Fig. 34: Determination of Mitotic index by FACS using H3pS10 antibody. A. Plot 
representing the determination of MI in clone 200SA549I8(16) bearing 8 integrations of 
two I-SceI sites in incompatible orientations. B. Plot representing the determination of MI 
in wild type A549 cells. Cells were either treated with 0.5 Gy X-rays or transfected with 
pEGFP-I-SceI-GR construct, or were untreated both in the presence and absence of 
Caffeine. MI was determined after 0, 1 and 3h post induction of damage. 
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3.2.10 Determination of induction of DSBs by I-SceI using EGFP-
tagged 53BP1 and live cell imaging 
53BP1 was identified as a protein that interacts with p53 through its BRCT domain. 
BRCT domain, first described at the carboxyl terminus of the breast cancer protein 
BRCA1, occurs predominantly in proteins involved in cell cycle checkpoint functions 
responsive to DNA damage. Upon exposure to IR, 53BP1 is hyperphosphorylated in an 
ATM dependent manner and relocalizes rapidly to form discrete nuclear foci. These foci 
colocalize with Nbs1 and γ-H2AX foci, which have been shown to localize at sites of 
DNA DSBs. Furthermore, 53BP1 is required for the accumulation of p53 protein, G2-M 
checkpoint arrest and the intra-S-phase checkpoint in response to IR damage [37, 148]. 
We utilize here a construct expressing the EGFP-tagged version of 53BP1 protein (a 
kind gift from Prof. T. Halazonetis) for determination of induction of DSBs by I-SceI 
utilizing live cell imaging. 
Since live cells cannot be stained with protein labeling dyes or by fluorescence-tagged 
antibodies, constructs expressing fluorescence-tagged proteins are the reagents of 
choice. For example, fluorescence-tagged DNA repair proteins-expressing-constructs 
are transfected 24 hours prior to irradiating the cells. After induction of damage, these 
proteins may be recruited to the sites of DSBs and become visible as foci. The objective 
of our experiment was to detect the induction of DSBs by studying the formation of 
EGFP-tagged 53BP1 foci in cells transfected with the I-SceI expression construct. 
A clone bearing 8 pairs of I-SceI sites in incompatible orientations (200SA549I8(16)) 
along with wild type A549 cells were used for the experiments. Results from live cell 
imaging have been plotted in Figure 36, which show the deployment and dissociation 
kinetics of EGFP-53BP1 foci tracked over a period of 24 hours. It was intriguing that 
most of the tracked green cells underwent apoptosis (as visualized by disruption of cell 
nucleus). This was observed for all of the three experiments performed, where both the 
EGFP-53BP1 and the I-SceI expression construct were transfected. This phenomenon 
was seldom observed in cells where only the construct expressing EGFP-53BP1 was 
transfected. This suggests that cells receiving the I-SceI expression construct may 
undergo apoptosis. Figure 36C represents foci kinetics of EGFP-53BP1 in wild type 
A549 cells irradiated with 1Gy X-rays which serves as a positive control. The cells were 
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nucleofected with the EGFP-53BP1 expressing construct 24 hours before irradiation. 
The cells were irradiated in 3-well live cell imaging chambers and immediately moved to 
a position under the microscope for capturing the images. The cells were maintained in 
Leibovitz media supplemented with 10% FBS. A number of cells were tracked over a 
period of approx. 2 hours post irradiation. The plotted graph shows the EGFP-53BP1 
foci kinetics in a representative cell. The 53BP1 foci number reaches 28 within 5 min of 
1Gy X-rays exposure and then falls to background levels at around 2 hours post 
irradiation. 
Figure 36A and B represent the foci kinetics of EGFP-53BP1 in two cells of a clone with 
8 pairs of I-SceI sites in incompatible orientations (200SA549I8(16)). In both plots, we 
observe the baseline foci of 2-3 in both cells which reaches a maximum of 
approximately 9 foci at 24 hours before reaching baseline levels again. Approximately 
10 cells were tracked over a period of 20 hours after transfection of pCMV-I-SceI-3xNLS 
construct, but as mentioned earlier; most of these cells underwent apoptosis midway 
through the 20 hour period where an increase in foci number was observed.  
Figure 35 represents still images of cells with EGFP-53BP1 foci after transfection with 
pCMV-I-SceI-3xNLS construct. 
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Fig. 35: A-C: Representative images of cells with EGFP-53BP1 foci. 200SA549I8(16) 
clone was transfected with a construct expressing EGFP-53BP1. 24 hours later, the cells 
were transfected with I-SceI expression construct and the cells were tracked for a period 
of 20 hours. 
E. Foci kinetics of EGFP-53BP1 after induction of DSBs by I-SceI. The film strip 
shows still images of a single cell tracked over a period of 8 hours from the time of 
appearance of 53BP1 foci after transfection with pCMV-I-SceI-3xNLS. 
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Figure 36 Figures representing the kinetics of induction and disappearance of 
EGFP-53BP1 foci in 1 Gy irradiated and I-SceI expression construct transfected 
cells. A, B. Represents EGFP-53BP1 foci kinetics of two cells of a clone 
200SA549I8(16) transfected with pCMV-I-SceI-3xNLS and tracked over a period 
of 20 hours post transfection. C. Represents EGFP-53BP1 foci kinetics in wild type 
A549 cells irradiated with 1Gy of X-irradiation. 
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Fig. 37: Induction of apoptosis after induction of DSBs by I-SceI. Live cell imaging 
film strips showing still images of cells undergoing apoptosis after transfection with 
pCMV-I-SceI-3xNLS tracked over a period of 20h.  
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4 Discussion  
4.1 Transfection approach versus repair pathway choice 
Certain aspects of D-NHEJ are optimally studied using in vivo plasmid-based assays 
and standard cell transfection protocols. While these assays recapitulate important 
aspects of D-NHEJ, several reports show that they fail to reproduce the marked 
reduction in DNA end joining efficiency of genomic DSBs observed in a variety of D-
NHEJ mutants. Here we report that much of this discrepancy derives from the 
transfection method used. We demonstrate that while plasmid electroporation generates 
plasmid end joining results in the different mutants closely reflecting rejoining of genomic 
DSBs, plasmid lipofection-generated results show a nearly wild type plasmid end joining 
efficiency in D-NHEJ mutants.  
In experiments where transfections were performed with LipofectamineTM reagent, the 
results exactly correspond to the earlier published results where not much variations or 
reductions were observed in the DNA end joining capacity of D-NHEJ deficient cells of 
Chinese hamster or rodent origin. We obtained, on the other hand, interesting results 
with the Nucleofector® technology, an electroporation method, where the manufacturer 
claims that conditions have been optimized for the DNA to be delivered directly into the 
nucleus, which seems to mimic the actual environment where DSBs occur. With this 
mode of transfection, we could demonstrate that the DNA end joining capability of D-
NHEJ mutants was critically compromised in all of the LIG4-/-, and Ku80 and DNA-PKcs-
mutants used. 
We observed that the difference in rejoining efficiency of the Ku80-deficient xrs-6 cells 
was not so pronounced between the two techniques as in the case of LIG4 deficiency, 
and the DNA-PKcs mutant XR-C1-3 cells, which show a large reduction in rejoining 
when tested with nucleofection, but only a marginal when tested with lipofection. The 
level of rejoining remained in Ku80-deficient cells low for both the techniques, although 
percent rejoining was nearly double to that seen after lipofection. 
Although transfection and rejoining efficiencies varied from cell line to cell line and from 
experiment to experiment, when viewed from a wider perspective, the common 
interpretation that nucleofection provides a method better reflecting the response of the 
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mutants to genomic DSBs remains valid.  To exclude that variations in the distribution of 
cells throughout the cell cycle caused the variations in rejoining efficiency observed with 
the different transfection methods, we checked in all individual experiments the cell 
cycle distribution by FACS analysis. In all experiments described here the amount of 
linear DNA transfected did not exceed 250ng, as higher amount caused saturation.   
 
4.1.1 Determination of plasmid intracellular compartmentalization after 
lipofection and nucleofection 
Careful analysis of results obtained from confocal imaging demonstrated that after 
lipofection, most of the transfected plasmid DNA fluorescence signal was localized in the 
cytoplasm in the form of aggregates with nuclear plasmid DNA aggregates present in 
some cells, which is in agreement with earlier reports that the transport of plasmid DNA 
into the nucleus in Lipofection depends on cell division. On the other hand, after 
nucleofection, no such inhibitions or demarcations were observed and DNA was 
localized randomly in the entire cell showing a markedly increased nuclear signal (See 
Fig. 17C). 
To date, similar studies had not dealt with the analysis of the intracellular distribution of 
transfected plasmid, and confined themselves to the visualization of DNA aggregates 
inside the cell, often overlooking the high amount of diffuse signal in the nucleus or the 
cytoplasm. Hence, we decided to measure the distribution in the entire cell of CX-
Rhodamine signal intensity, which would include both diffuse and aggregated DNA 
signals. Our intensity measurements data from in vivo DNA tracking experiments (Fig. 
17C) were in agreement with earlier published results [149], but we observed that it was 
important to measure the signals (both diffuse and punctate) over the entire cell rather 
than focusing on the punctate DNA signals. We would conclude that the method of 
analysis employed in the present work provides a better basic mechanistic regarding the 
parameters determining the differences in NHEJ function observed between the two 
techniques.  
On the basis of the above observation we hypothesize that the preferential delivery by 
nucleofection of plasmid DNA into the nucleus determines the fate of linearized plasmid 
DNA. One of the most prominent aspects of these experiments is that we always 
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observed higher transfection efficiencies for Nucleofection than for lipofection in all the 
cell lines tested. A word of caution here is that the transfection efficiencies are 
calculated with expression of GFP as an endpoint and not by the amount of DNA 
transported inside the cell. It is relevant that DNA tracking experiment show very similar 
intracellular transport of transfected plasmid after nucleofection and lipofection. This 
raises the question as to whether the intracellular plasmid localization also influences 
expression. According to a recent publication, where the authors trailed the 
microinjected DNA inside the nucleus and the cytoplasm, it was noted that plasmid in 
the cytoplasm is removed quickly and efficiently, whereas plasmid microinjected into the 
nucleus appears non motile [150]. 
It is possible that plasmid DNA transfected by lipid-based systems like LipofectamineTM 
distribute mainly in the cytoplasm where it is acted upon by various cellular systems and 
be eventually discarded, damaged or degraded, reaching the nucleus with reduced 
efficiency and partially inactivated [150]. There is also a distinct possibility that improper 
compartmentalization of constructs remaining in cytoplasm may be acted upon by B-
NHEJ generating thus the effects observed. 
On the other hand, in Nucleofection, although the majority of the plasmid is transfected 
into the cytoplasm, a measurable amount is directly translocated into the nucleus. This 
extrachromosomal DNA may be compartmentalized and rendered non-motile by 
attachment to the nuclear matrix, thus protecting it somehow and making it available for 
processing by the nuclear DNA repair machinery. Thus, we speculate that when DNA is 
delivered quickly and efficiently into the nucleus, it remains in its original state without 
being acted upon by nucleases and that the DNA repair machinery can efficiently act 
upon in a manner similar to that of genomic DNA. The same may hold true for the 
subsequent expression. This may be the reason why D-NHEJ remains a key player, and 
why its deficiency is directly translated to major plasmid rejoining deficiencies in our 
nucleofection experiments. 
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4.1.2 Effect of nucleases on plasmid end joining assays performed using 
different transfection technologies 
We further set out to examine whether the presence of nucleases in the cytoplasm or 
the nucleus of the cells had a role to play in the observed variations in NHEJ response. 
For this purpose, we treated cells with 100nM of the nuclease inhibitor ATA before 
transfection [151-154]. To our surprise, we could not reproduce the results published 
earlier with LipofectamineTM [151], as transfection with this reagent was close to 
completely inhibited after treatment of the cells with ATA. This may be due the 
inactivation by ATA of the reagent.  
On the other hand, transfection was successful after nucleofection, but no significant 
differences were observed between the transfection efficiencies and percent rejoining in 
the presence or absence of ATA. Hence, these experiments failed to elucidate the 
possible role of nucleases in the effects under study. However, the results with ATA 
should be interpreted cautiously as ATA is not a very specific nuclease inhibitor and is 
also known to be a potent inhibitor of other cellular enzymes.  
Another possibility worth introspecting and mentioning is that the plasmid system used 
here may be optimal for measuring DNA end joining in vivo, firstly, because the Pem-1 
intron provides an excellent buffer region for normal DNA repair-associated deletion 
events without losing expression of EGFP. Secondly, the prospect that the construct 
harbors scaffold/matrix attachment sequences in the Pem1 intron may provide 
processing advantages and may generate a model system mimicking genomic DNA.  
Thus, we conclude that proper compartmentalization of transfected plasmid in the cell 
nucleus is a prerequisite for assaying the function of D-NHEJ. In all other instances, the 
function of B-NHEJ is mainly assayed. 
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4.2 Models of complex lesions using special arrangements of I-SceI 
recognition sites 
4.2.1 Ionizing radiation induces clustered DNA damage 
Energy deposition by ionizing radiation in the cell leads to several consequences, the 
most deleterious of which is its interaction with DNA, the basic unit of organization of a 
cell’s genomic information. This energy deposition occurs within psec and leads to both 
direct and indirect interactions with DNA generating a vast array of damages. These 
damages include single strand breaks (SSBs), DSBs, sugar backbone and base 
damages along with other types of subtle damages like formation of heat labile sites[54] 
and probably other unknown types of damage. Due to this of induced damage, it is 
difficult to pin the type, which led to the observed effect. Whether the death of cells is 
due to additive effect from such damages, or whether only a certain forms of damage 
cause the cell mortality and other consequences is not known with certainty.  
In addition, individual forms of damage, for example DSBs, can be of various 
configurations and can lead to deleterious effects not only depending on their location in 
the genome, but also their mutual spacing or their distance from other forms of damage. 
DNA lesions are not spread across the DNA molecule randomly, but they have a definite 
pattern that follows closely the pattern of energy deposition. As a result of this Multiple 
Damaged Sites (MDS) are generated. [14] Radiation physics clearly show that clustering 
of ionizations occurs with low LET radiation and predominates after high LET radiation. 
The consequences of this clustering are not yet known and are a topic of active 
investigation, but are thought to cause the higher efficacy of high LET radiation. 
Scientists have tried to model different kinds of lesions and their effects theoretically, but 
these models are conjectural and lack experimental base.  
 
4.2.2 Designing an I-SceI based model system to mimic clustered lesions 
With this project, we set out to design and develop a model system for studying the 
ability of a cell to deal with simple and clustered DSBs.  
We designed oligonucleotides with single I-SceI sites along with oligos bearing pairs of 
I-SceI sites placed either in direct or opposite orientation and separated by 200 bp. This 
distance was chosen because it represents the average amount of DNA accommodated 
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in one nucleosomal unit (including spacer region). We reasoned that when both sites are 
digested a situation destabilizing chromatin will be generated. It is known that DNA is 
wound in 1.7 turns around a nucleosome (see Figure 37). MDS clusters can spread 
across both strands of DNA, giving rise to damage separated by about 80-150 bp, which 
is nearly the length of DNA wrapped around the nucleosome.  
 
 
 
 
 
 
 
 
 
Fig. 37: Structure of Chromatin Organization. Courtesy www.molecularstation.com 
 
For this study, we utilized homing endonucleases for induction of DSBs in the 
mammalian cell genome. There are numerous reports, which have either utilized 
random integration of the homing endonuclease site in the genome, or have performed 
targeted integration of such sites at specific chromosomal loci [155-159]. We differed 
from other studies by integrating a several pairs of I-SceI sites in the cells and by 
employing different orientations and complexities. To maximize the number of 
integrations in the genome, we adapted the Sleeping Beauty Transposon system to our 
work. 
 
4.2.3 Survival of clones bearing I-SceI sites at different orientations 
A goal of the project was to compare the biological effectiveness of single versus pairs 
of closely located DSBs. As is evident from the results, survival curves with clones 
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bearing single I-SceI sites revealed that simple DSBs can be successfully handled by 
the cell showing no cell lethality even at relatively high numbers of integrations. 
To increase the complexity of the damage and mimic the effects of high LET radiation, 
we designed oligonucleotides that sustain pairs of DSBs in close proximity (200bp). 
Assuming that both sites are cut at the same time and that the piece of DNA in between 
gets lost, a DSB will be generated that may pose greater problems to the cell than the 
single DSB. To further enhance the severity of the resulting DSB we varied the 
orientation of the I-SceI sites to generate (after loss of the intervening piece of DNA) 
ends that were either compatible or incompatible to direct ligation. 
Survival curves for clones with pairs of I-SceI sites showed strong killing which appeared 
to increase with increasing number of integrations. Although it is tempting to speculate 
that DSBs with incompatible ends will have more severe biological effects than those 
with compatible ends, the results obtained thus far do allow such conclusion. Of course 
it is possible that DSBs with incompatible ends lead with a higher probability to deletions 
after repair, as our PCR indeed suggest, but more work will be need to arrive to more 
firm conclusions.  
Damage caused by IR is thought to particularly complex within spurs and blobs leading 
to the formation of locally multiply damaged sites (LMDS). Increase in LET increases the 
number of spurs/blobs created at a given dose, which augments the severity of the 
inflicted damage to DNA. Spurs and blobs contain a number of ion pairs and have 
dimensions comparable to the DNA or even to small regions of chromatin. It is 
postulated that the average energy deposited in a spur is in the range of 100 eV. For low 
LET radiation, an average distance of 100 nm between two spurs is estimated, 
corresponding to a distance of approx. 300bp across a DNA molecule. This is similar to 
the 200bp of distance chosen in our work, vindicating thus our design. The distance of 
approximately 200 bps between the two DSBs may also prove to be more lethal than 
DSBs which are farther apart but this will need further experimentation. Nucleosome 
destabilization induced with this constellation of DSBs may result in local disruption of 
the nuclear architecture leading to disruption of various active processes like 
transcription, replication, etc. and may prove a hindrance to D-NHEJ or HRR.  
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Endonucleases are known to have preference for cutting at open chromatin sites like 
transcription start sites (TSS), and thus the chance of losing the intervening fragment 
becomes higher due to absence of nucleosomal arrangement at the site, leaving DNA 
sequences vulnerable to be lost in space. The scenarios originating from such breaks 
have not been investigated before and our study provides some tools in addressing 
such questions. 
 
4.2.4 Correlation of G2-PCC results with colony formation assay 
As observed in the colony formation experiments, extensive cell lethality is witnessed 
upon induction of DSBs by I-SceI. Since classical cytogenetics did not allow the 
conclusive scoring of chromosomal aberrations at a number that would explain cell 
killing, we introduced the G2-PCC assay [143] with the objective of scoring aberrations 
in the G2 phase of the cell cycle before they get repaired, which would increase their 
number. Calyculin A induced G2-PCC was performed with various clones bearing I-SceI 
sites in both compatible and incompatible orientations along with wild type A549 control. 
Although more chromosome damage was detected with this method, the breaks scored 
were present in low number in only few cells. The discrepancy between cell killing and 
formation of chromosome aberrations is puzzling and under investigation at present. As 
discussed below, we entertain the possibility that this is due to the loss to apoptosis of a 
large fraction of damaged cells. 
 
4.2.4.1 β-AraA enhances G2-PCC breaks in clones bearing pairs of I-SceI 
sites 
As a further step, we used the known DNA synthesis inhibitor and potent radiosensitizer 
β-AraA [136, 137] in the G2-PCC assay[142]. We reasoned that treatment of cells with 
β-AraA would lead to inhibition of I-SceI induced DSBs, which in turn would result in an 
increase in the number of G2-PCC breaks. Results obtained for G2-PCC after treatment 
with β-AraA showed increase in PCC breaks, but failed to reconciliate cell survival and 
chromosome aberration data. Similar conclusions could be drawn from the G2-PCC 
results obtained after treatment with hypertonic solution.  
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4.2.5 Closely spaced DSBs induced by I-SceI lead to loss of the intervening 
sequence. 
The results obtained by PCR on the fate of the intervening sequence between the two I-
SceI sites yielded very interesting results. The intervening sequence had not only been 
lost, but both I-SceI sites were also lost along with some deletions both upstream and 
downstream of these sites. Other studies have reported loss of the intervening fragment 
between two homing endonuclease sites when excised simultaneously [91] [90]. In 
many model systems utilizing two I-SceI sites for studying DSB repair, the loss of 
intervening sequence would restore a promoter or a fluorescence/antibiotic-resistance-
conferring gene. The problem with such selection is that other events like end 
processing which disrupt completely the reporter genes go unnoticed, thus creating a 
bias on the outcome. It is likely that cells where end processing leads to larger deletions 
remain unreported. 
We would like to hypothesize that loss of the fragment leads to a severe disruption of 
nuclear architecture, but it remains possible that cell with such deletion survive the 
insult. We do not know the frequency of such events, but it would be of interest to 
determine whether cell lethality depends on such events or whether it is induced by 
other more complex types of chromosome aberrations. 
The results obtained with the PCR analysis of the ends after transfection with I-SceI-
expressing construct implicates error-prone canonical NHEJ in the repair of the induced 
DSBs, resulting in loss of nucleotides during the rejoining event as reported previously 
[91]. If the process of rejoining would have taken place by a pathway with 
unquestionable fidelity, the sites of I-SceI would have been restored in case of non-
simultaneous incision, or a single site of I-SceI would have resulted in case of 
simultaneous cutting. It should be also kept in mind that the outcome of the rejoining 
event is dependent on the phase of the cell cycle where incision with I-SceI takes place. 
Classical NHEJ is known to function predominantly in G1 phase of the cell cycle with 
HRR taking over in S and G2 phases [160]. It is possible that when these breaks are 
induced in G2 phase of the cell cycle, the outcome of simultaneous incision at the two 
sites and repair would yield a different configuration at the site, as HRR would strive to 
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restore the original sequence. This could explain our results of G2-PCC obtained with β-
AraA, as some unpublished results from our group show that it inhibits HRR. Hence, 
treatment with β-AraA leads to inhibition of DSB processing, thus increasing G2-PCC 
breaks.  
We speculate that cells may not be killed by the loss of the integral fragment as the lost 
sequence is a part of the integrated sequence and not part of their genome. However, 
disruption or destabilization of chromatin organization may be a reason for cell lethality.  
 
4.2.6 No clear G2 checkpoint witnessed after I-SceI-induced DSBs  
Determination of G2-checkpoint activation by measuring the G2 phase content of cells 
over a period of 24 hours post transfection with the I-SceI expression construct showed 
a slight increase in G2 content as compared to wild type A549 cells, but the increase 
was small and could not be interpreted on the basis of the potentially induced DSBs. 
This may be due to that fact that endonuclease-induced DSBs occur over a period of 
time (hours), depending on the expression of the construct and thus simultaneous 
presence of all DSBs is not possible. In this way the DSB threshold of approx. 20 DSBs 
[24, 161] required for the activation of the G2 checkpoint may not be reached. However, 
the possibility should also be entertained that most damage cells die of apoptosis and 
the observed accumulation of cells reflects a large proportion of untransfected cells.  
 
4.2.7 No clear fluctuations in Mitotic Index after induction of I-SceI DSBs 
This method was employed to study the activation of G2 checkpoint on DSB induction, 
because the above described method is not sensitive enough for deciphering minor 
changes in checkpoint activation. Histone H3 phospho-Serine 10 staining is a sensitive 
assay for the determination of MI, which is an indirect indication of G2 checkpoint 
function. Results with this assay, although they occasionally showed a decrease in MI, 
the difference was not significant enough to draw any definitive conclusions. This result 
may arise due to the reasons discussed above. 
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4.2.8 Live cell imaging shows apoptosis in a majority of cells after 
expression of I-SceI 
Live cell imaging experiments performed with a construct expressing EGFP-53BP1 in 
clones bearing 8 pairs of I-SceI sites showed an increase in EGFP-53BP1 foci when 
tracked over a period of 16-24 hours after transfection. An interesting phenomenon was 
witnessed in this experiment that may have important ramifications for the interpretation 
of many of the results presented above. We observed that the majority of cells which 
showed appearance of EGFP-53BP1 foci underwent apoptosis with only a few cells 
showing kinetics of appearance and disappearance of 53BP1 foci over a period of 24 
hours. The tendency for apoptosis could explain the results with the colony and 
chromosome aberration formation, where extensive cell lethality is observed but 
chromosomal aberrations cannot be seen. Thus, effectively transfected cells may 
activate apoptotic signals and may not attempt repair. In any event, analysis of 
chromosome aberrations in an apoptotic cell is not possible.  
Our work tests and partially confirms the hypothesis that clustering of DSBs at distances 
affecting nucleosomal stability may be highly lethal for the cell. With these results, it is 
clear that our attempt to model simple and complex lesions has achieved its share of 
success but would require further refinement to be able to answer some intriguing 
questions arising out of this study. The most important challenge is to confirm that 
apoptosis confounds the results obtained and to develop ways and means to overcome 
this limitation. 
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5 Conclusions 
In our pursuit to decode and understand radiation induced damage response in 
mammalian cells without actually utilizing radiation, we designed the two studies, one 
involving linearized plasmids mimicking broken DNA whose rejoining can be quantified 
by fluorescent proteins in cells deficient in D-NHEJ pathway; the second on developing 
homing endonuclease-based model systems utilizing Sleeping Beauty Transposition for 
the study of simple and complex DNA lesions. 
In our in vivo plasmid assay, end joining of lipofected DNA showed only a small 
dependence on LIG4, DNA-PKcs or Ku than in end joining of genomic DNA, whereas, 
end joining of nucleofected DNA showed a strong dependence on above mentioned D-
NHEJ components. The preferential delivery by nucleofection of plasmid DNA into the 
nucleus probably determines the fate of linearized plasmid. Thus, proper 
compartmentalization of transfected plasmid in the cell nucleus is a prerequisite for 
assaying the function of D-NHEJ. On the other hand, in lipofection, where the plasmid 
DNA remains in the cytoplasm until the cell divides, the function of B-NHEJ is mainly 
assayed. 
The results prove that nucleofection provides a method better reflecting the response of 
the mutants to genomic DSBs and hence is a technique of choice for studying DSB 
repair by plasmid rejoining in vivo. 
Results from our second study show conclusively that increasing lesion complexity leads 
to increased cell lethality as cells with simple DSBs (single I-SceI sites) showed no cell 
killing in complete contrast to the cells inflicted with complex DSBs (2 closely spaced I-
SceI sites). We also observed dose dependent effect of killing by I-SceI-induced DSBs, 
i.e. clones with increasing numbers of integrations showed increased cell lethality in cell 
survival assays. We conclude that the breaks induced by I-SceI probably led to 
nucleosome loss resulting in local disruption of chromatin, thus driving the cell to 
undergo apoptosis 
Conclusions  
 119
Overall, the findings validate our model system for the study of the biological effects of 
complex DNA lesions and suggest a substantially enhanced killing potential for DSB 
pairs as compared to single DSBs, which are a hallmark of high LET radiation.
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6 Future Strategies 
 
Although results from our plasmid tracking experiment showed that plasmid localization 
after transfection is the key factor in determining the outcome of plasmid based DNA 
repair assays, mechanistic studies for determining whether the plasmid DNA is acted 
upon by different repair pathways when compartmentalized in different locations in the 
cell need to be carried out. 
 
For the study of simple and complex lesions, initial designs of constructs included 
oligonucleotides with a single (simple lesions) or two I-SceI sites (complex lesions) in 
different orientations separated by 200bp. Due to the clear difference observed between 
clones bearing single and pairs of DSBs, it would be interesting to vary the distances 
between the two I-SceI sites to span two to four nucleosomes and determine the cellular 
response to such lesions. To add another degree of lesion complexity to the system, 
constructs can be designed bearing four or more I-SceI sites separated by varied 
distances and orientations and integrating them in the genome using SB transposase. 
These lesions would in principle mimic clustered type of damage, which is a hallmark of 
high LET radiation. A targeted approach can also be adopted for integrating these 
constructs bearing varied lesion complexities in specific loci of chromosomes with 
fluorescence or antibiotic-based reporter assays to signal the induction of I-SceI induced 
DSBs. 
 
As extensively discussed in the thesis, the percentage of killing observed with clones 
bearing two sites in cell survival assay does not correlate to our G2-PCC data, which is 
surprising as it is known that cell lethality has a one to one correlation with asymmetrical 
chromosomal aberrations. It is imperative to determine the possible reasons for this 
effect. Live cell imaging experiments with EGFP-tagged 53BP1 gave some hints to the 
possibility of apoptosis playing a role in the extensive cell killing observed. For taking it 
to the next step, experiments would have to be performed to determine the extent of 
apoptosis and devise ways to prevent it. Experiments also need to be performed to rule 
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out the possibility that plasmid toxicity of the I-SceI expression constructs is responsible 
for some of the effects observed on cell lethality and chromosomal aberration formation. 
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8 Appendix 
Appendix 1: Settings for bivariate flow cytometry 
 
Flow cytometry:    COULTER EPICS XL  
Sheath Speed:    middle 
 Total cells sampled:   20000 
 Maximal running duration:  900 seconds 
 Working mode:    Manual 
 
Program/Parameter DNA-PI 
H3-pS10-FITC 
FS-PMT ( volt) 
FS-Gain 
SS-PMT (volt) 
SS-Gain 
AUX-PMT (volt) 
AUX-Gain 
55 
2 
400 
1 
300 
2 
Excitation of PI 
PI-Filter spectrum 
PI-PMT (volt) 
PI-Gain 
PI-Signal 
PI-GATE 
Discriminator 
488 nm 
655-735 nm 
520 
2 
Linear 
Single cell 
PI>3 
Excitation of FITC 
FITC Filter 
FITC-PMT (volt) 
FITC-Gain 
FITC-Signal 
FITC-GATE 
488 nm 
490-550 nm 
520 
2 
Linear 
FITC positive 
 
 
 
 
 
 
Appendix 2: Antibody dilution for bivariate flow cytometry 
 
Protein Name Primary Antibody Secondary Antibody 
H3-pS10 mAb 1:200 FITC 1:300 
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Appendix 3: Settings for Confocal microscope and Imaris® 
software 
 
Settings for Leica TCS SP5 Confocal microscope 
 
Instrument Parameter Setting:  Confocal LDM    
Argon laser intensity:  50% 
Objective: HCX PL APO lambda blue 63.0x1.40 
OIL UV 
Speed:    400Hz 
Image size:    246.03 μm x 246.03 μm   
 
 Pixel size:    481.46 nm x 481.47nm   
     
Sequential Scan:   Between stacks 
Scan direction:   Bidirectional    
 . 
Step size:    0.5 μm 
Resolution:    512x512 
 
 
 
 
Program/Parameter DAPI γ-H2AX 
Alexa 568 
Excitation 
Laser Intensity 
Filter Range 
PMT 
Smart Gain Offset 
405 nm 
16% 
410-550 nm 
850 V 
-2% 
488 nm 
23% 
495-550 nm 
540 V 
-5% 
Minimal Foci Size 
(Imaris®) 
Threshold setting for 
Imaris® 
  
 
0.5 µm 
17 
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Buffers and Solutions 
 
Appendix 4: Tissue culture and flow cytometry 
 1x Phosphate Buffered Saline (PBS)  
  Dissolve the following in 800ml Double distilled water (ddH2O). 
8 g of NaCl 
0.2 g of KCl 
1.44 g of Na2HPO4 
0.24 g of KH2PO4 
Adjust pH to 7.4. Adjust volume to 1L with additional ddH2O. Sterilize by 
autoclaving and store at 4°C. 
 
 Trypsin-EDTA (Trypsin 0.05%, EDTA 0.02%) 
  0.5 g of Trypsin 
0.2 g of EDTA 
Adjust the volume to 1L with 1x PBS. 
Sterilize by passing through 0.22 μm filter and store at -20 °C. 
 
 Sodium azide (NaN3 0.02%) 
  10 g of NaN3 
Adjust the volume to 100 ml with ddH2O. 
Store at RT. 
 
 Freezing Solution A 
5mM KH2PO4 
25mM KOH 
30mM NaCl 
20mM L (+) lactic acid 
5mM Dextrose 
0.5mM MgCl2 
200mM Sorbitol in Milli-Q  
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 Freezing Solution B 
5mM KH2PO4 
25mM KOH 
30mM NaCl 
20mM L (+) lactic acid 
5mM Dextrose 
0.5mM MgCl2 
200mM Sorbitol in 80% Milli-Q and 20% DMSO 
 
 BrdU stock solution (10mM) 
  0.307 g of BrdU. 
Adjust the volume to 100 ml with 1x PBS. 
Sterilize by passing through 0.22 μm filter and store at -20°C in dark. 
 
 100X Propidium iodide (4 mg/ml) solution 
400 mg of PI. 
Adjust the volume to 100 ml with ddH2O. 
Store at -20°C in dark. 
 
 100X RNase (6.2 mg/ml) solution 
620 mg of RNase 
Adjust the volume to 100 ml with MQ  
Store at -20°C in dark. 
 
 1M HCl 
Add 10 ml 12M HCl to 50 ml ddH2O. 
Adjust the volume to 120ml with ddH2O. 
Store at RT. 
 
 FACS Permeabilization solution 
PBS + 0.25% Triton X-100 
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2.5 ml Triton X-100 
Adjust the volume to 1000 ml with PBS. 
Store the solution at RT in dark. 
 
 FACS blocking buffer  
PBS + 0.05% Tween-20 + 1% BSA 
10 g BSA 
2.5 ml 20% Tween-20 
Adjust the volume to 1000 ml with PBS. 
Store at -20°C. 
 
Appendix 5: Electrophoresis 
 Electrode buffer (4X) 
0.1M Tris 
0.768M Glycine, pH 8.3 
 
 4x Tris/SDS pH 6.8, stacking gel buffer 
Dissolve 6.05 g Tris-base in 40ml ddH2O. 
Adjust pH to 6.8 with 1N HCl. 
Add H20 to 100 ml. 
Add 0.4 g SDS. 
Store at 4°C. 
 
 4x Tris/SDS pH 8.8, resolving gel buffer 
Dissolve 91 g Tris-base in 300 ml ddH2O. 
Adjust to pH 8.8 with 1 N HCl. 
Add H2O to 500 ml. 
Add 2 g SDS. 
Store at room temperature. 
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 5x SDS electrophoresis buffer 
15.1 g Tris-base. 
72.0 g Glycine 
5.0 g SDS 
Add ddH2O to 1000 ml. 
Store at room temperature. 
 
 TBE (0.5X) 
45mM Tris. 
45mM Boric acid. 
1mM EDTA. 
 
 6x SDS sample buffer 
7 ml 4x Tris/SDS pH 6.8 stacking gel buffer 
3.0 ml glycerol 
1 g SDS 
0.93 g DTT 
1.2 mg Bromophenol blue 
Add ddH2O to 10 ml. 
Store in 1 ml aliquots at -20 °C. 
 
 1X Transfer Buffer (Western blot transfer buffer) 
Dissolve the following in 1600ml ddH2O. 
28.8 g of Glycine 
6.04 g Tris base 
Add 200 ml methanol. 
Adjust the volume to 2000 ml with ddH2O. 
Store at 4°C. 
 
 Tween-20 20%  
200 ml Tween-20 
Appendix 
 137
Adjust the volume to 1000ml with ddH2O. 
Store the solution at RT in dark. 
 
 TBST (PBS-0.05% Tween-20, washing buffer) 
2.5 ml 20% Tween-20  
Adjust the volume to 1000 ml with PBS. 
Store the solution at RT in dark. 
 
 PBST-milk (PBST-5% ,Tween-20, washing buffer) 
5g of milk (blot grade) 
Adjust the volume to 1000 ml with ddH2O. 
Store the solution at 4°C in dark. 
 
 Coommassie Staining Solution 
0.02% Coommassie Brilliant Blue G250 
2% (w/v) Phosphoric acid 
5% Aluminium sulphate 
10% Ethanol 
 
Appendix 6: Cell  Fractionation 
 Hypotonic Buffer 
10mM HEPES, pH 7.5 
1.5mM MgCl2 
5mM KCl 
0.2 mM PMSF 
0.5mM DTT  
 
 Low Salt Buffer 
20mM HEPES, pH 7.9 at 4°C 
1.5mM MgCl2 
0.02M KCl  
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0.2mM EDTA  
0.2mM PMSF 
0.5mM DTT 
 
 High Salt Buffer 
10mM HEPES, pH 7.9 at 4°C 
1.6 M KCl 
1.5 mM MgCl2 
 
 Dialysis Buffer 
25mM Tris/HCl pH 7.5 at 4°C 
10% Glycerol 
50mM EDTA 
1mM EDTA 
0.5 mM DTT 
0.2mM PMSF  
 
 DAPI solution 
2µg/ml DAPI 
0.1M Tris 
0.1M NaCl 
5mM MgCl2 
0.05% TritonX-100 
 
Appendix 7. Buffers for Cytogenetics 
 
 Hypotonic solution 
0.56 g KCl. 
Adjust the volume to 100ml with ddH2O. 
Prepare fresh at the time of experiment. 
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 Carnoy’s fixative  
3 parts Methanol + 1 part acetic acid. 
75 ml methanol 
25 ml acetic acid 
Prepare fresh at the time of experiment. 
 
 
Appendix 8: Buffers for Southern Blotting 
 20x SSPE (pH7.4) 
3M NaCl  
0.2M NaH2PO4.H2O 
0.02M EDTA 
 
 Depurination Solution (500 ml) 
  0.2NHCl 
Mix 10 ml of fuming HCl with 490 ml of ddH2O 
 
 Denaturation Solution 
  1.5M NaCl 
 0.5M NaOH 
 
 Neutralization Solution 
  1M Tris (pH7.4) 
 1.5 M NaCl 
 
 Washing Solution I 
  2x SSPE 
 0.5% SDS 
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 Washing Solution II 
  2x SSPE 
 0.1% SDS 
 
 Washing Solution III 
  0.1x SSPE 
 0.1% SDS 
 
 Washing Solution IV 
  0.1x SSPE 
 
 
 
 
 
Table 1: Cell lines used in in vivo experiments. 
 
Name         Description Culture Medium References 
A549 Human alveolar basal cell 
carcinoma of epithelial 
origin 
McCoy's 5A + 
 10% FBS 
[162] 
xrs-6 Chinese hamster ovary MEM + 10% FBS [134] 
XR-C1-3 Chinese hamster ovary MEM + 10% FBS  
CHO9 Chinese hamster ovary MEM + 10% FBS  
p53-/-
LIG4+/+ 
(WT) 
Mouse Embryonic 
Fibroblast 
DMEM + 10% 
FBS 
[133] 
Lig4-/- p53-/- Mouse Embryonic 
Fibroblast 
DMEM + 10% 
FBS 
[133] 
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Table 2: Oligonucleotide Sequences 
 
Oligonucleotides 
 
Sequence 
Fwnest/O/SB 5’ GACTGTGCCTTTAAACAGC 3’ 
 
Rev460/SB  5’ ACTTTCCACACCCTAACT 3’ 
 
1SB1NS CCCGAGCTCGAATTCTACCCGCGGAGATCTCCCAACC 
CTGAATAGGGATAACAGGGTAATAACCCTGAACCCCT 
CGAGTCTA GACCCGAATTCGGTACCGGG 
 
200A CCCGAGCTCGAATTCTACCCGCGGAGATCTCCCAACC 
CTGAATAGGGATAACAGGGTAATATCATTTTCGGTAG 
CAAGTTTAAGCATCAATTCTAGGATGAAGGAGGGAATT 
TGTAAATCTTCAGCCCATTGCAGATGACGCGGCCGCG 
ATACTAGTGACAAGCTTGATGGATCCTGAGATATCTAC 
GGCAGACCGCAATTAAAGACCTTGCTGTGTCTTCCTGA
TTGTAAGGAGTCCACATACGATGGTGCTTGTCTATAGG
GATAACAGGGTAATAACCCTGAACCCCTCGAGTCTAG 
ACCCGAATTCGGTACCGGG 
 
 
200B CCCGAGCTCGAATTCTACCCGCGGAGATCTCCCAACC 
 CTGAATAGGGATAACAGGGTAATATCATTTTCGGTAG 
CAAGTTTAAGCATCAATTCTAGGATGAAGGAGGGAATT 
TGTAAATCTTCAGCCCATTGCAGATGACGCGGCCGCG 
ATACTAGTGACAAGCTTGATGGATCCTGAGATATCTAC 
GGCAGACCGCAATTAAAGACCTTGCTGTGTCTTCCTGA
CTTGTAAGGAGTCCACATACGATGGTGCTTGTCTAATT 
ACCCTGTTATCCCTAAACCCTGAACCCCTCGAGTCTAG
ACCCGAATTCGGTACCGGG 
 
 
NB: Text in RED is the I-SceI sites in compatible and incompatible 
orientations. 
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Table 3: Antibodies 
 
 
Antibodies MW(kDa) Type Manufacture Cat. number Dilution 
 
Primary Ab      
γ-H2AX 14 mAb Abcam Ab22551 1:200 
Secondary Ab      
Mouse IgG-
Alexa 568 
 pAb Molecular 
Probes, 
Invitrogen 
A11004 1:400 
 
 
 
 
Table 4: Software used for quantification of results 
 
 
 
 
                  Program         Software     
                 Image Quant          Molecular Dynamics (Invitrogen), USA 
                 Quantity One         Bio-Rad, USA 
                 Adobe  Illustrator         Adobe Systems Inc. USA 
                 SigmaPlot 10         Systat Software Inc. USA 
                 MS Office         Microsoft, USA 
                 Unicorn         Aekta (GE Healthcare) 
                 Wincycle®         Beckman Coulter, USA 
                 Imaris®         Bitplane AG; Switzerland 
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